US7826901B2 - Generation of therapy programs and program groups - Google Patents

Generation of therapy programs and program groups Download PDF

Info

Publication number
US7826901B2
US7826901B2 US10/831,971 US83197104A US7826901B2 US 7826901 B2 US7826901 B2 US 7826901B2 US 83197104 A US83197104 A US 83197104A US 7826901 B2 US7826901 B2 US 7826901B2
Authority
US
United States
Prior art keywords
neurostimulation therapy
program
copy
neurostimulation
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US10/831,971
Other versions
US20040267330A1 (en
Inventor
Michael T. Lee
Steven M. Goetz
Nathan A. Torgerson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Priority to US10/831,971 priority Critical patent/US7826901B2/en
Assigned to MEDTRONIC, INC. reassignment MEDTRONIC, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LEE, MICHAEL T., GOETZ, STEVEN M., TORGERSON, NATHAN A.
Publication of US20040267330A1 publication Critical patent/US20040267330A1/en
Priority to US11/698,655 priority patent/US8068915B2/en
Application granted granted Critical
Publication of US7826901B2 publication Critical patent/US7826901B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37235Aspects of the external programmer
    • A61N1/37247User interfaces, e.g. input or presentation means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36082Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128Control systems
    • A61N1/36146Control systems specified by the stimulation parameters
    • A61N1/36182Direction of the electrical field, e.g. with sleeve around stimulating electrode
    • A61N1/36185Selection of the electrode configuration
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/903Radio telemetry

Definitions

  • the invention relates to neurostimulation therapy and, more particularly, to generation of therapy programs and program groups used for delivery of neurostimulation therapy to a patient.
  • Implantable medical devices may be used to deliver neurostimulation therapy to patients to treat a variety of symptoms or conditions such as chronic pain, tremor, Parkinson's disease, epilepsy, incontinence, or gastroparesis.
  • An implantable medical device may deliver neurostimulation therapy via leads that include electrodes located proximate to the spinal cord, pelvic nerves, or stomach, or within the brain of a patient.
  • the implantable medical device delivers neurostimulation therapy in the form of electrical pulses.
  • a clinician may select values for a number of programmable parameters in order to define the neurostimulation therapy to be delivered to a patient. For example, the clinician may select an amplitude, which may be a current or voltage amplitude, and pulse width for a stimulation waveform to be delivered to the patient, as well as a rate at which the pulses are to be delivered to the patient. The clinician may also select as parameters particular electrodes within an electrode set to be used to deliver the pulses, and the polarities of the selected electrodes. A group of parameter values may be referred to as a program in the sense that they drive the neurostimulation therapy to be delivered to the patient.
  • the process of selecting values for the parameters that provide adequate results can be time consuming, and may require a great deal of trial and error before a “best” program is discovered.
  • the “best” program may be a program that is better in terms of clinical efficacy versus side effects experienced and power consumption than other programs tested.
  • the process of selecting electrodes and the polarities of the electrodes can be particularly time-consuming and tedious.
  • the clinician may need to test all possible combinations of electrodes within the set implanted in the patient, or a significant portion thereof, in order to identify a “best” combination of electrodes and their polarities.
  • the clinician may test combinations by manually specifying each combination to test based on intuition or some idiosyncratic methodology, and recording notes on the efficacy and side effects of each combination after delivery of stimulation via that combination. In this manner, the clinician is able to later compare and select from the tested combinations.
  • implantable medical devices commonly deliver spinal cord stimulation therapy (SCS) to a patient via two leads that include eight electrodes per lead and provide well over one million potential electrode combinations.
  • SCS spinal cord stimulation therapy
  • the invention is directed to techniques that may be employed by a programming device to allow a clinician or patient to identify combinations of electrodes from within an electrode set implanted in a patient that enable delivery of desirable neurostimulation therapy by an implantable medical device.
  • the programmer may execute an electrode combination search algorithm to select combinations of electrodes to test in a non-random order. By selecting combinations in a non-random order, the programmer may allow the clinician or patient to more quickly identify desirable electrode combinations.
  • the programmer may identify a position of a first cathode electrode for subsequent combinations, and then select electrodes from the electrode set to test with the first cathode as anodes or additional cathodes based on the proximity of the electrodes to the first cathode.
  • the programmer may identify a first position within the electrode set, which may be a central position within the electrode set, and control the implantable medical device to test the electrode located at that position as the first cathode.
  • the programmer may then test additional electrodes from within the set as the first cathode in an order based on proximity to the first cathode.
  • the programmer may receive input from the clinician or patient indicating which tested electrode is the first cathode, and then control the implantable medical device to test other electrodes of the set in combination with the first cathode.
  • Undesignated electrodes may be tested as anodes and additional cathodes in an order based on proximity to the first cathode. In some cases, only a subset of the undesignated electrodes may be tested to avoid testing redundant electrode combinations, i.e., electrode combinations that would produce substantially the same current flow as an electrode combination already tested.
  • the programmer may store information for each combination tested, and the information may facilitate the identification of desirable electrode combinations by the clinician. For example, the programmer may present a list of tested combinations and their associated information, and the list may be ordered according to the information.
  • the clinician may create neurostimulation therapy programs that include identified desirable program combinations.
  • the clinician or patient may use the programmer to test a variety of values of other neurostimulation therapy program parameters, such as pulse amplitude, pulse rate, pulse width and duty cycle, with the identified electrode combinations, i.e., to test a variety of neurostimulation therapy programs.
  • the programmer may collect rating information for each of the tested neurostimulation therapy programs.
  • the clinician may use the programmer to identify a plurality of desirable neurostimulation therapy programs from among those tested during the programming session for use in controlling delivery of neurostimulation therapy to the patient by the implantable medical device.
  • the programmer provides a neurostimulation therapy program replication function.
  • the programmer selects one of the neurostimulation therapy programs identified during the programming session, e.g., receives a selection of one of the programs made by the clinician, and receives a replication command from the clinician.
  • the programmer In response to the replication command, the programmer generates one or more copies of the selected neurostimulation therapy program.
  • the programmer may change one or more of the parameters of the selected program, e.g., pulse amplitude, pulse rate, pulse width, duty cycle, or electrode combination.
  • the programmer may provide one or more copies that are identical to the selected program, and the patient or clinician may adjust one or more parameters of the copies.
  • the implantable medical device delivers therapy to the patient according to program groups, i.e., groups of two or more neurostimulation therapy programs.
  • the implantable medical device may deliver the two or more programs of a program group to the patient substantially simultaneously.
  • the implantable medical device may deliver each neurostimulation therapy pulse according to a different one of the plurality of programs of a program group.
  • the programmer may automatically generate one or more program groups that include two or more of a plurality of neurostimulation programs identified as desirable during programming session.
  • the programmer may associate each of a plurality of identified neurostimulation therapy programs with one or more of a plurality of program categories, and may generate the groups, e.g., assign programs to groups, based on their associated program categories.
  • the programmer may automatically generate the program groups in response to receiving a program group generation command from the clinician.
  • Each of the program categories is related to a characteristic of neurostimulation therapy programs.
  • the programmer may categorize a neurostimulation therapy program by paresthesia location, e.g., left-side, right-side, or bilateral, or based on the location of electrodes included within its electrode combination.
  • the programmer may generate a program group to include programs associated with different categories, e.g., programs associated with different paresthesia or electrode locations.
  • a program group that includes programs associated with different paresthesia or electrode locations may be able to, for example, address complex pain patterns, and avoid conflicts that can arise when sequential pulses are delivered according to different programs via the same electrodes.
  • the programmer may categorize a neurostimulation therapy program according to stimulation intensity, e.g., high, medium or low, according to posture, e.g., standing or sitting, according to patient activity, e.g., running or sitting, according to time of day, e.g., daytime or evening, according to symptom intensity, e.g., high or low, or according to stimulation side effects, e.g., high or low.
  • stimulation intensity e.g., high, medium or low
  • posture e.g., standing or sitting
  • patient activity e.g., running or sitting
  • time of day e.g., daytime or evening
  • symptom intensity e.g., high or low
  • stimulation side effects e.g., high or low.
  • the programmer may generate a program group to include programs associated with the same category, e.g., programs associated with the same intensity, posture, activity, time of day, symptom intensity, or side effects.
  • a program group that includes programs associated with the same stimulation intensity level, symptom intensity level, posture, or activity may be selected by the patient to address a current symptom level, or when the patient assumes a particular posture or undertakes a particular activity.
  • the programmer combinatorially generates program groups from a set of neurostimulation therapy programs identified during a programming session.
  • the programmer may automatically generate a plurality of program groups by generating multiple combinations of neurostimulation therapy programs that comply with one or more criteria related to program categories.
  • the programmer may order the programs within each category according to rating information, e.g., collected during a neurostimulation programming session, and may maintain a preference for use of more “highly” rated programs when combining programs to create groups, e.g., may create program groups based on both the program categories and the rating information. For example, the programmer may exclude “poorly” rated programs from program groups, or may assign higher rated programs to groups more frequently than lower rated programs.
  • the invention is directed to a method in which a first electrode of a set of electrodes implanted in a patient is selected to be included in a combination of electrodes for use in delivery of neurostimulation to the patient.
  • the first electrode may be a cathode for the combination.
  • a sequence of additional electrodes of the set to test for inclusion in the combination is automatically selected according to locations of the additional electrodes relative to the first electrode.
  • the additional electrodes may be tested for inclusion of one of the additional electrodes as an anode for the combination.
  • the invention is directed to a computer-readable medium containing instructions.
  • the instructions cause a programmable processor to select a first electrode of a set of electrodes implanted in a patient to include in a combination of electrodes for use in delivery of neurostimulation to the patient.
  • the instructions also cause a processor to automatically select a sequence of additional electrodes within the set to test for inclusion in the combination according to locations of the additional electrodes relative to the first electrode.
  • the invention is directed to a device that includes a processor.
  • the processor selects a first electrode of a set of electrodes implanted in a patient to include in a combination of electrodes for delivery of neurostimulation therapy to the patient.
  • the processor also automatically selects a sequence of additional electrodes to test for inclusion in the combination according to locations of the additional electrodes relative to the first electrode.
  • the device may be a programming device associated with one of a clinician and the patient.
  • the invention is directed to a method in which a search algorithm is executed to control an implantable medical device to test combinations of electrodes in an order that is based on the proximity of the electrodes of the combinations to a central position within the set.
  • Information identifying at least one of the tested combinations is stored as part of a neurostimulation therapy program that defines neurostimulation therapy to be delivered to the patient by the implantable medical device.
  • the invention is directed to a method in which a neurostimulation therapy program that includes a set of neurostimulation therapy parameters is selected, and a replication command is received from a user. A copy of the selected neurostimulation therapy program is generated in response to the replication command, and the selected neurostimulation therapy program and the copy are provided to at least one of a programming device or a medical device. A selected one or more of the neurostimulation therapy program and the copy controls delivery of neurostimulation therapy to a patient by the medical device.
  • the invention is directed to a device that includes a user interface, a communication circuit, and a processor.
  • the processor selects a neurostimulation therapy program that includes a set of neurostimulation therapy parameters, receives a replication command from a user via the user interface, generates a copy of the selected neurostimulation therapy program in response to the replication command, and provides the selected neurostimulation therapy program and the copy to at least one of a programming device or a medical device via the communication circuit.
  • a selected one or more of the neurostimulation therapy program and the copy controls delivery of neurostimulation therapy to a patient by the medical device.
  • the invention is directed to a computer-readable medium comprising instructions.
  • the instructions cause a programmable processor to select a neurostimulation therapy program that includes a set of neurostimulation therapy parameters, receive a replication command from a user, generate a copy of the selected neurostimulation therapy program in response to the replication command, and provide the selected neurostimulation therapy program and the copy to at least one of a programming device or a medical device.
  • a selected one or more of the neurostimulation therapy program and the copy controls delivery of neurostimulation therapy to a patient by the medical device.
  • the invention is directed to a method in which a plurality of neurostimulation therapy programs are identified during a neurostimulation therapy programming session, and each of the identified neurostimulation therapy programs is associated with at least one of a plurality of program categories.
  • Each of the program categories is related to a characteristic of at least one of the identified neurostimulation therapy programs.
  • a plurality of program groups is automatically generated based on the program categories, each of the program groups including at least two of the identified neurostimulation therapy programs.
  • the invention is directed to a device that includes a memory and a processor.
  • the memory stores a plurality of neurostimulation therapy programs identified during a neurostimulation therapy programming session.
  • the processor associates each of the identified neurostimulation therapy programs with at least one of a plurality of program categories, and automatically generates a plurality of program groups based on the program categories.
  • Each of the program categories is related to a characteristic of at least one of the identified neurostimulation therapy programs, and each of the program groups including at least two of the identified neurostimulation therapy programs
  • the invention is directed to a computer-readable medium comprising instructions.
  • the instructions cause a programmable processor to identify a plurality of neurostimulation therapy programs during a neurostimulation therapy programming session, associate each of the identified neurostimulation therapy programs with at least one of a plurality of program categories, and automatically generate a plurality of program groups based on the program categories.
  • Each of the program categories is related to a characteristic of at least one of the identified neurostimulation therapy programs, and each of the program groups including at least two of the identified neurostimulation therapy programs.
  • the invention may provide a number of advantages. For example, the invention may allow a clinician to more quickly identify desirable electrode combinations, reducing the overall amount of time the clinician spends programming neurostimulation therapy for a patient.
  • programmer according to the invention may select electrode combinations in a systematic manner to test in an order such that electrode combinations that are more likely to enable desirable therapy are selected earlier in the search. Consequently, the clinician may be able to end the search before all potential electrode combinations have been tested if one or more desirable combinations have already been identified.
  • the invention may reduce the time required to identify desirable electrode combinations by automating selection of each new combination to test.
  • the invention may also avoid testing redundant combinations, i.e., combinations that are substantially equivalent to combinations already tested. Avoiding redundant combinations may further reduce the amount of time required for the search.
  • the invention may improve the search process by collecting amplitude information, and rating information that is entered by the clinician or patient, for each combination tested.
  • a programmer according to the invention may present a list of tested electrode combinations to the clinician, ordered according to one or both of the amplitude and rating information, allowing the clinician to more easily identify and select desirable combinations.
  • a bracket of untested electrode combinations that are similar to identified electrode combinations may be used to create programs that are provided to the patient. Providing bracket programs to the patient allows the patient to experiment with the programs to “finely tune” the neurostimulation therapy provided by the implantable medical device without requiring the clinician to be involved.
  • a programmer may allow a clinician to quickly generate a plurality of similarly desirable programs for selection, modification and use by a patient.
  • the programmer may provide a plurality of similar programs with various intensities and battery consumption rates, e.g., a high intensity and low intensity version of a selected program.
  • the programmer may enable selection of a program that addresses a current symptom level, e.g., a pain level which may vary based on patient posture, activity or time of day, with a comparatively lower rate of battery consumption.
  • a current symptom level e.g., a pain level which may vary based on patient posture, activity or time of day
  • the programmer may associate the selected program and the copies with respective postures, activities, times of day, symptom states, or side effect states, e.g., may label a selected program and a copy as “sitting” and “standing,” “high” and “low,” or “daytime” and “nighttime,” respectively.
  • the patient may use a patient programmer to adjust parameters of program copies to create similarly desirable programs with different intensities and battery consumption rates to, for example, address different symptom levels associated with different postures or activities.
  • a programmer according to the invention may be able to quickly provide a clinician with a plurality of program groups that include combinations of neurostimulation therapy programs.
  • use of program categories may allow the programmer to generate programs groups that include desirable and/or logical combinations of programs.
  • FIG. 1 is a diagram illustrating an example system for programming and delivering neurostimulation therapy.
  • FIG. 2 is a diagram illustrating an example electrode set that may be implanted within the patient.
  • FIG. 3 is a block diagram illustrating an example programming device that allows a user to identify desirable electrode combinations for neurostimulation therapy programs.
  • FIG. 4 is a flow diagram illustrating an example method that may be employed by a programming device to select and execute an electrode combination search algorithm according to the invention.
  • FIG. 5A and 5B are flow diagrams illustrating an example electrode combination search algorithm that may be executed by a programming device.
  • FIGS. 6A-6K are diagrams illustrating example matrices that illustrate positions within exemplary electrode set configurations and orders in which electrodes within such electrode sets may be tested according to electrode combination search algorithms consistent with the invention.
  • FIG. 7 is a flow diagram illustrating an example method that may be employed by a programming device to test an electrode combination according to the invention.
  • FIG. 8 is a flow diagram illustrating an example method that may be employed by a programming device to replicate a selected neurostimulation therapy program.
  • FIG. 9 is a flow diagram illustrating an example method that may be employed by a programming device to automatically generate program groups based on program categories associated with neurostimulation therapy programs.
  • FIG. 1 is a diagram illustrating an example system 10 for programming neurostimulation therapy for and delivering neurostimulation therapy to a patient 12 .
  • System 10 includes an implantable medical device 14 that delivers neurostimulation therapy to patient 12 .
  • IMD 14 may be an implantable pulse generator, and may deliver neurostimulation therapy to patient 12 in the form of electrical pulses.
  • IMD 14 delivers neurostimulation therapy to patient 12 via leads 16 A and 16 B (collectively “leads 16 ”).
  • Leads 16 may, as shown in FIG. 1 , be implanted proximate to the spinal cord 18 of patient 12 , and IMD 14 may deliver spinal cord stimulation (SCS) therapy to patient 12 in order to, for example, reduce pain experienced by patient 12 .
  • SCS spinal cord stimulation
  • leads 16 shown in FIG. 1 are not limited to the configuration of leads 16 shown in FIG. 1 or the delivery of SCS therapy.
  • one or more leads 16 may extend from IMD 14 to the brain (not shown) of patient 12 , and IMD 14 may deliver deep brain stimulation (DBS) therapy to patient 12 to, for example, treat tremor or epilepsy.
  • DBS deep brain stimulation
  • one or more leads 16 may be implanted proximate to the pelvic nerves (not shown) or stomach (not shown), and IMD 14 may deliver neurostimulation therapy to treat incontinence or gastroparesis.
  • the invention is not limited to systems in which an IMD delivers neurostimulation therapy to patient 12 .
  • an external neurostimulator e.g., a transcutaneuous electrical stimulation (TENS) device, or a trial neurostimulator may deliver neurostimulation therapy to patient 12 .
  • TESS transcutaneuous electrical stimulation
  • trial neurostimulator may deliver neurostimulation therapy to patient 12 .
  • IMD 14 delivers neurostimulation therapy to patient 12 according to one or more neurostimulation therapy programs.
  • a neurostimulation therapy program may include values for a number of parameters, and the parameter values define the neurostimulation therapy delivered according to that program.
  • the parameters may include pulse voltage or current amplitudes, pulse widths, pulse rates, duty cycles and the like.
  • each of leads 16 includes electrodes (not shown in FIG. 1 ), and the parameters for a program may include information identifying which electrodes have been selected for delivery of pulses according to the program, and the polarities of the selected electrodes.
  • Electrode combinations refer to combinations of single or multiple cathode electrodes and single or multiple anode electrodes. Stimulation current flows between the cathodes and anodes for delivery of neurostimulation therapy.
  • System 10 also includes a clinician programmer 20 .
  • Clinician programmer 20 may, as shown in FIG. 1 , be a handheld computing device.
  • Clinician programmer 20 includes a display 22 , such as a LCD or LED display, to display information to a user.
  • Clinician programmer 20 may also include a keypad 24 , which may be used by a user to interact with programmer 20 .
  • display 22 may be a touch screen display, and a user may interact with clinician programmer 20 via display 22 .
  • a user may also interact with clinician programmer 20 using peripheral pointing devices, such as a stylus or mouse.
  • Keypad 24 may take the form of an alphanumeric keypad or a reduced set of keys associated with particular functions.
  • a clinician (not shown) may use clinician programmer 20 to program neurostimulation therapy for patient 12 , as will be described in greater detail below.
  • System 10 also includes a patient programmer 26 , which also may, as shown in FIG. 1 , be a handheld computing device.
  • Patient 12 may use patient programmer 26 to control the delivery of therapy by IMD 14 .
  • patient 12 may select a current neurostimulation therapy program or group of neurostimulation therapy programs from among the programs or program groups preprogrammed by the clinician, or may adjust one or more parameters of a therapy program or program group.
  • Patient programmer 26 may also include a display 28 and a keypad 30 to allow patient 12 to interact with patient programmer 26 .
  • display 28 may be a touch screen display, and patient 12 may interact with patient programmer 26 via display 28 .
  • Patient 12 may also interact with patient programmer 26 using peripheral pointing devices, such as a stylus, mouse, or the like.
  • clinician and patient programmers 20 , 26 are not limited to the hand-held computer embodiments illustrated in FIG. 1 .
  • Programmers 20 , 26 according to the invention may be any sort of computing device.
  • a programmer 20 , 26 according to the invention may a tablet-based computing device, a desktop computing device, or a workstation.
  • IMD 14 , clinician programmer 20 and patient programmer 26 may, as shown in FIG. 1 , communicate via wireless communication.
  • Clinician programmer 20 and patient programmer 26 may, for example, communicate via wireless communication with IMD 14 using radio frequency (RF) telemetry techniques known in the art.
  • RF radio frequency
  • Clinician programmer 20 and patient programmer 26 may communicate with each other using any of a variety of local wireless communication techniques, such as RF communication according to the 802 . 11 or Bluetooth specification sets, infrared communication according to the IRDA specification set, or other standard or proprietary telemetry protocols.
  • Clinician programmer 20 and patient programmer 26 need not communicate wirelessly, however.
  • programmers 20 and 26 may communicate via a wired connection, such as via a serial communication cable, or via exchange of removable media, such as magnetic or optical disks, or memory cards or sticks.
  • clinician programmer 20 may communicate with one or both of IMD 14 and patient programmer 26 via remote telemetry techniques known in the art, communicating via a local area network (LAN), wide area network (WAN), public switched telephone network (PSTN), or cellular telephone network, for example.
  • LAN local area network
  • WAN wide area network
  • PSTN public switched telephone network
  • cellular telephone network for example.
  • clinician may use clinician programmer 20 to create neurostimulation therapy programs.
  • clinician programmer 20 allows the clinician to identify electrode combinations that enable IMD 14 to deliver neurostimulation therapy that is desirable in terms of, for example, symptom relief, coverage area relative to symptom area, and side effects.
  • Clinician programmer 20 may also allow the clinician to identify electrode combinations that enable IMD 14 to deliver effective neurostimulation therapy with desirable device performance characteristics, e.g., low battery consumption.
  • Clinician programmer 20 controls IMD 14 to test electrode combinations in order to allow a clinician to identify desirable combinations in an efficient manner. As will be described in greater detail below, clinician programmer 20 may select electrode combinations to test based on an electrode combination search algorithm. In particular, according to such an algorithm, clinician programmer 20 may first control IMD 14 to test one or more electrodes to identify the electrode which will act as a first cathode electrode, and then control IMD 14 to test combinations that include the first cathode in an order that is based on the proximity of other electrodes in the combination to the first cathode.
  • clinician programmer 20 may allow the clinician to more quickly identify desirable electrode combinations, reducing the overall amount of time the clinician spends programming neurostimulation therapy for patient 12 .
  • clinician programmer 20 may select electrode combinations to test in an order such that electrode combinations that are more likely to enable desirable therapy are selected earlier in the search. Consequently, the clinician may be able to end the search before all potential electrode combinations have been tested if one or more desirable combinations have already been identified, saving the amount clinician and patient time required to achieve an efficacious electrode combination.
  • programmer 20 may reduce the time required to identify desirable electrode combinations by automating selection of each new combination to test. Additionally, clinician programmer 20 may improve the search process by collecting amplitude and rating information for each combination tested. As will be described in greater detail below, clinician programmer 20 may present a list of electrode combinations to the clinician, ordered according to one or both of the amplitude and rating information, allowing the clinician to more easily identify and select desirable combinations.
  • the clinician or patient 12 may use clinician programmer 20 to test variety of values of other neurostimulation therapy program parameters, such as pulse amplitude, pulse rate, pulse width and duty cycle, with the identified electrode combinations, i.e., to test a variety of neurostimulation therapy programs.
  • Clinician programmer 20 may collect rating information, e.g., information relating to efficacy, power consumption and/or side effects, from patient 12 for each of the tested neurostimulation therapy programs. Based on this testing, the clinician may use clinician programmer 20 to identify a plurality of desirable neurostimulation therapy programs from among those tested during the programming session for use in controlling delivery of neurostimulation therapy to patient 12 by IMD 14 .
  • clinician programmer 20 provides a neurostimulation therapy program replication function.
  • clinician programmer 20 selects one of the neurostimulation therapy programs identified during the programming session, e.g., receives a selection of one of the programs made by the clinician, and receives a replication command from the clinician.
  • clinician programmer 20 In response to the replication command, clinician programmer 20 generates one or more copies of the selected neurostimulation therapy program.
  • clinician programmer 20 may allow a clinician to quickly generate a plurality of similarly desirable programs for selection and use by patient 12 .
  • clinician programmer 20 may change one or more of the parameters of the selected program. For example, pulse amplitude, pulse width, pulse rate, duty cycle, or a combination thereof may be changed to provide a plurality of similar programs with various intensities and battery consumption rates.
  • clinician programmer 20 may provide a “high intensity” and “low intensity” version of a selected program.
  • clinician programmer 20 may allow patient 12 ,to select a program that addresses a current symptom level, e.g., pain level which may vary based on patient posture, activity, or time of day, with a comparatively lower rate of battery consumption.
  • clinician programmer 20 may associate the selected program and the copies with respective postures, activities, times of day, symptom intensity states, or program side effect states, e.g., may label a selected program and a copy as “sitting” and “standing,” “active” and “inactive,” “daytime” and “nighttime,” or “high” and “low,” respectively.
  • patient 12 may be unaware of the differences between the intensities of the program and the copies, and either IMD 14 or patient programmer 26 may collect information regarding the use of the program and the copies to determine whether patient 12 will accept a program with a lower intensity and battery consumption rate.
  • clinician programmer 20 may provide one or more copies that are identical to the selected program, and patient 12 may adjust one or more parameters of the copies to create similarly desirable programs with different intensities and battery consumption rates to, for example, address different symptom levels associated with different postures, activities, or times of day.
  • IMD 14 delivers therapy to patient 12 according to program groups, i.e., groups of two or more neurostimulation therapy programs.
  • IMD 14 may deliver the two or more programs of a program group to patient 12 substantially simultaneously.
  • IMD 14 may deliver each neurostimulation therapy pulse according to a different one of the plurality of programs of a program group.
  • clinician programmer 20 may automatically generate one or more program groups that include two or more of a plurality of neurostimulation programs identified as desirable during programming session.
  • clinician programmer 20 may associate each of a plurality of identified neurostimulation therapy programs with one or more of a plurality of program categories, and generate the groups, e.g., assign programs to groups, based on their associated program categories.
  • Clinician programmer 20 may automatically generate the program groups in response to receiving a program group generation command from the clinician.
  • Each of the program categories is related to a characteristic of neurostimulation therapy programs.
  • clinician programmer 20 may categorize a neurostimulation therapy program by paresthesia location, e.g., left-side, right-side, or bilateral, or based on the location of electrodes included within its electrode combination.
  • clinician programmer 20 may generate a program group to include programs associated with different categories, e.g., programs associated with different paresthesia or electrode locations.
  • a program group that includes programs associated with different paresthesia or electrode locations may be able to, for example, address complex pain patterns, and avoid conflicts that can arise when sequential pulses are delivered according to different programs via the same electrodes.
  • clinician programmer 20 may categorize a neurostimulation therapy program according stimulation intensity, e.g., high, medium or low, according to posture, e.g., standing or sitting, according to patient activity, e.g., running or sitting, according to time of day, e.g., daytime or evening, according to symptom intensity, e.g., high or low, or according to stimulation side effects, e.g., high or low.
  • stimulation intensity e.g., high, medium or low
  • posture e.g., standing or sitting
  • patient activity e.g., running or sitting
  • time of day e.g., daytime or evening
  • symptom intensity e.g., high or low
  • stimulation side effects e.g., high or low.
  • clinician programmer 20 may generate a program group to include programs associated with same category, e.g., programs associated with same intensity, posture, activity, time of day, symptom intensity, or side effects.
  • a program group that includes programs associated with same stimulation intensity level, symptom intensity level, posture, or activity may be selected by patient 12 to address a current symptom level, or when patient 12 assumes a particular posture or undertakes a particular activity.
  • clinician programmer 20 may, as indicated above, communicate with IMD 14 via telemetry techniques known in the art.
  • clinician programmer 20 may communicate with IMD 14 via an RF telemetry head (not shown).
  • Information identifying desirable combinations of electrodes identified by the clinician may be stored as part of neurostimulation therapy programs.
  • Neurostimulation therapy programs, program copies, and/or program groups, created or generated as described above, may be transmitted to IMD 14 via telemetry, and/or may be transmitted to patient programmer 26 via any wired or wireless communication technique.
  • the programs and/or program groups may be available for selection, e.g., by patient 12 , to control delivery of therapy by IMD 14 .
  • FIG. 2 is a block diagram illustrating an example configuration of leads 16 .
  • lead 16 A includes electrodes 40 A-H
  • lead 16 B includes electrodes 401 -P.
  • Electrodes 40 A-P may be ring electrodes.
  • Electrodes 40 collectively form an electrode set 42 implanted within patient 12 .
  • electrode set 42 includes eight electrodes on each of the two leads 16 , which, as shown in FIG. 1 , are implanted such that they are substantially parallel to each other and spinal cord 18 , on substantially opposite sides of spinal cord 18 , at approximately the same height relative to spinal cord 18 , and oriented such that the distal ends of leads 16 are higher relative to the spinal cord than the proximal ends of leads 16 . Therefore, the illustrated configuration of electrode set 42 may be described as a two-by-eight, side-by-side, upwardly oriented configuration.
  • programmer 20 may be used to identify desirable combinations of electrodes within electrode sets that are configured in any way, and used to provide any type neurostimulation therapy.
  • a single lead including four or eight electrodes, two leads including four electrodes per lead, in-line leads, and offset leads, all of which may be oriented in any manner relative to patient 12 provide electrode set configurations that may be searched by programmer 20 .
  • IMD 14 may deliver neurostimulation via any combination of electrodes 40 .
  • IMD 14 may independently activate each electrode 40 of set 42 to act as a cathode or anode for a combination, and each combination will include at least one cathode and at least one anode.
  • a combination may include a single electrode 40 acting as the cathode, with a can of IMD 14 , i.e., the IMD housing, acting as the anode for the combination.
  • an electrode combination electrons flow from the one or more electrodes acting as anodes for the combination to the one or more electrodes acting as cathodes for the combination.
  • the current between anodes and cathodes may stimulate neurons between and proximate to the anodes and cathodes.
  • an electrode combination enables desirable neurostimulation therapy when current is delivered in a direction and with an intensity sufficient to stimulate specific neurons or a sufficient number of specific neurons to alleviate a symptom without causing unacceptable side effects.
  • an electrode combination enables desirable neurostimulation therapy when the symptom is alleviated without resorting to undesirably high pulse amplitudes.
  • clinician programmer 20 selects individual electrodes 40 or electrode combinations to test to allow a clinician to identify desirable electrode combinations according to an electrode search algorithm.
  • Clinician programmer 20 may select an appropriate search algorithm based on the configuration of electrode set 42 , and may select electrodes 40 or electrode combinations based on the selected search algorithm.
  • Clinician programmer 20 controls IMD 14 to test a selected electrode 40 or electrode combination by controlling IMD 14 to deliver neurostimulation via the selected electrode 40 or combination.
  • Clinician programmer 20 may first control IMD 14 to test one or more of electrodes 40 individually to identify the individual electrode or electrodes 40 which will act as a first cathode.
  • a clinician implants leads 16 in a location such that the center of electrode set 42 is proximate to an area that the clinician believes should be stimulated in order to alleviate symptoms. Therefore, clinician programmer 20 may test electrodes 40 as the first cathode in an order such that electrodes 40 located centrally within electrode set 42 , e.g., electrodes 40 D-E and 40 L-M illustrated in FIG. 2 , are tested before peripherally located electrodes.
  • clinician programmer 20 will continue to test individual electrodes 40 in such an order until one of the electrodes 40 that enables desirable neurostimulation therapy when activated as the first cathode is identified. Initially locating a first cathode provides a “coarse” optimization of electrode combinations, allowing clinician programmer 20 and the clinician to quickly identify the general area to which neurostimulation therapy should be delivered.
  • Clinician programmer 20 may then control IMD 14 to test electrode combinations that include the first cathode.
  • Clinician programmer 20 may control IMD 14 to try different ones of electrodes 40 as the first anode in a pair with the first cathode, and may add additional anodes and/or cathodes.
  • Clinician programmer 20 may control IMD 14 to test remaining electrodes 40 as first anodes, and additional anodes or cathodes, in an order that is based on the proximity of the remaining electrodes 40 to the electrode 40 acting as the first cathode for the electrode combination. The order may be based on decreasing proximity of the remaining electrodes 40 to the electrode acting as the first cathode, e.g., electrodes will be tested in order of increasing distance from the first cathode.
  • electrode combinations that include cathodes and anodes in closer proximity may be more likely to enable desirable neurostimulation therapy. Therefore, by testing electrode combinations in an order based on decreasing proximity of the other electrodes 40 , clinician programmer 20 provides a “fine” optimization of electrode combinations, allowing the clinician to more quickly identify electrode combinations that enable more desirable neurostimulation therapy than the initial combination including the first cathode and the first location of the first anode. With this approach, the search for electrode combinations may proceed in a pattern or “orbit” in close proximity about an initially selected cathode or cathodes, and then extend outward into a more distant orbit as the search continues.
  • FIG. 3 is a block diagram illustrating an example configuration of clinician programmer 20 .
  • a clinician may interact with a processor 50 via a user interface 52 in order to identify electrode combinations, identify neurostimulation therapy programs, request neurostimulation therapy program replication, and request automatic program group generation, as described herein.
  • User interface 52 may include display 22 and keypad 24 , and may also include a touch screen or peripheral pointing devices as described above.
  • Processor 50 may also provide a graphical user interface (GUI) via user interface 52 to facilitate interaction with a clinician.
  • GUI graphical user interface
  • Processor 50 may include a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), discrete logic circuitry, or the like.
  • DSP digital signal processor
  • ASIC application specific integrated circuit
  • FPGA field-programmable gate array
  • Clinician programmer 20 also includes a memory 54 .
  • Memory 54 may include program instructions that, when executed by processor 50 , cause clinician programmer 20 to perform the functions ascribed to clinician programmer 20 herein.
  • processor 50 may execute a selected one of electrode combination search algorithms 56 stored within memory 54 to select individual electrodes 40 or electrode combinations to test to allow the clinician to identify desirable electrode combinations.
  • processor 50 may collect information relating to tested electrode combinations, and store the information in memory 54 for later retrieval and review by the clinician to facilitate identification of desirable electrode combinations.
  • Neurostimulation therapy programs 60 created by the clinician may be stored in memory 54 , and information identifying electrode combinations selected by the clinician to be utilized for one of programs 60 may be stored as part of the program within memory 54 .
  • a plurality of desirable programs 60 may be identified, and may be replicated or assigned to program groups by processor 50 .
  • Memory 54 may include any volatile, non-volatile, fixed, removable, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), CD-ROM, hard disk, removable magnetic disk, memory cards or sticks, nonvolatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, and the like.
  • RAM random access memory
  • ROM read-only memory
  • CD-ROM compact disc-read-only memory
  • NVRAM nonvolatile RAM
  • EEPROM electrically-erasable programmable ROM
  • flash memory and the like.
  • Processor 50 controls IMD 14 to test selected individual electrodes 40 or electrode combinations, by controlling IMD 14 to deliver neurostimulation therapy to patient 12 via the selected individual electrodes 40 or electrode combinations via a telemetry circuit 62 .
  • processor 50 controls IMD 14 to test selected neurostimulation therapy programs 60 , which include identified electrode combinations and other selected program parameters, by controlling IMD 14 to deliver neurostimulation therapy to patient 12 according to the selected program.
  • Processor 50 may transmit programs 60 that are identified as desirable, copies of one or more such programs, and/or program groups that include two or more such programs to IMD 14 via telemetry circuit 62 , or to patient programmer 26 via input/output circuitry 64 .
  • I/O circuitry 64 may include transceivers for wireless communication, appropriate ports for wired communication or communication via removable electrical media, or appropriate drives for communication via removable magnetic or optical media. Together, telemetry 62 and I/O circuitry 64 may form a communication circuit for clinician programmer 20 .
  • FIG. 4 is a flow diagram illustrating an example method that may be employed by clinician programmer 20 to select and execute an electrode combination search algorithm according to the invention.
  • Clinician programmer 20 and more specifically processor 50 of clinician programmer 20 , identifies a configuration of electrode set 42 ( 70 ), and selects an electrode combination search algorithm 56 based on the configuration ( 72 ).
  • Multiple algorithms 56 may be available for selection in order to allow clinician programmer 20 to address differences between electrode configurations, e.g., different numbers of leads and electrodes per leads.
  • each of algorithms 56 may employ the common search methodology that was discussed above, and is illustrated by FIGS. 5A and 5B discussed below.
  • Clinician programmer 20 may identify the configuration of electrode set 42 by, for example, receiving input from the clinician via user interface 52 indicating the configuration.
  • information identifying the configuration of electrode set 42 may be stored in memory 54 or a memory of IMD 14 at implant.
  • clinician programmer 20 may retrieve the information from memory 54 or from IMD 14 via telemetry circuit 62 .
  • Clinician programmer 20 then, as will be described in greater detail below, executes the selected search algorithm to select individual electrodes 40 and electrode combinations to test ( 74 ).
  • clinician programmer 20 may, as will also be described in greater detail below, store information 58 relating to that combination in memory 54 .
  • the information may include amplitude information, and/or rating information provided by one or both of the clinician and patient 12 .
  • Clinician programmer 20 may present a list of tested combinations to the clinician via display 22 ( 78 ).
  • the list may include the information relating to each combination, and in some embodiments, may be ordered according to information.
  • the list may facilitate identification of one or more desirable electrode combinations by the clinician.
  • the clinician may create neurostimulation therapy programs 60 that include identified electrode combinations ( 80 ), and clinician programmer 20 may store information identifying the electrode combinations selected by the clinician in memory 54 , and use the selected combinations to generate programs 60 .
  • clinician programmer 20 may automatically select electrode combinations for inclusion in programs 60 based on the information.
  • FIG. 5A and 5B are flow diagrams illustrating an example electrode combination search algorithm that may be executed by clinician programmer 20 .
  • clinician programmer 20 identifies an initial position within electrode set 42 ( 90 ), and controls IMD 14 to test an electrode 40 located at the initial position as the first cathode ( 92 ).
  • the initial position may be a central position within electrode set 42
  • programmer 20 may identify a central position within set 42 based on the configuration of set 42 .
  • programmer 20 may initially control IMD 14 to test electrode 40 E ( FIG. 2 ) as the first cathode.
  • the clinician may identify the initial position or the specific electrode 40 that the clinician believes should be tested first, and clinician programmer 20 may control IMD 14 to test the electrode 40 corresponding to input provided by the clinician.
  • Clinician programmer 20 determines whether an additional electrode 40 should be tested as the first cathode ( 94 ). Clinician programmer 20 may prompt the clinician to indicate whether an additional electrode 40 should be tested. If the clinician is satisfied with the first electrode 40 tested, clinician programmer 20 identifies the first electrode as the first cathode for subsequently tested combinations ( 98 ). However, if the clinician indicates that additional electrodes 40 should be tested, clinician programmer 20 may control IMD 14 to test additional electrodes 40 of electrode set 42 in an order based on decreasing proximity to the initial position until the clinician indicates that no more electrodes 40 should be tested or all electrodes 40 of electrode set 42 have been tested ( 96 ). At that point, programmer 20 may identify the first cathode ( 98 ) either as the last electrode 40 tested, or based on input from the clinician identifying which of the tested electrodes 40 should be identified as the first cathode.
  • clinician programmer 20 controls IMD 14 to test one of electrodes 40 as the first cathode, another one of electrodes 40 adjacent to the tested electrode, or the can of IMD 14 , acts as a first anode to form a cathode/anode pair.
  • clinician programmer 20 may determine based on input received from the clinician whether other electrodes 40 of electrode set 42 are to be tested as the first anode ( 100 ). If the clinician indicates that no additional electrodes are to be tested as the first anode, programmer may identify the already tested electrode 40 adjacent to the first cathode as the first anode ( 104 ).
  • clinician programmer 20 may control IMD 14 to test additional electrodes 40 of electrode set 42 in an order based on decreasing proximity to the first cathode until the clinician indicates that no more electrodes 40 should be tested or all electrodes 40 of electrode set 42 have been tested ( 102 ). At that point, clinician programmer 20 may identify the first anode ( 104 ) either as the last electrode 40 tested, or based on input from the clinician identifying which of the tested electrodes 40 should be identified as the first anode. Each first cathode/first anode pair tested forms an electrode combination.
  • FIG. 5B illustrates portions of the example algorithm that enable programmer 20 and the clinician to try adding anodes and/or cathodes to the existing first cathode/first anode pair.
  • programmer 20 selects electrodes to test as the additional anode or cathode.
  • the existing combination is the first cathode/first anode pair
  • the resulting combinations tested may include guarded cathode or guarded anode combinations known in the art.
  • clinician programmer 20 controls IMD 14 to test undesignated electrodes 40 of electrode set 42 in an order based on decreasing proximity to the first cathode ( 108 ) until programmer 20 receives an indication to stop testing electrodes 40 or until all electrodes 40 of electrode set 42 have been tested ( 110 ).
  • clinician programmer 20 receives an indication to try an additional cathode ( 112 )
  • programmer 20 controls IMD 14 to test undesignated electrodes 40 of electrode set 42 in an order based on decreasing proximity to the first cathode ( 114 ) until programmer 20 receives an indication to stop testing electrodes 40 or until all electrodes 40 of electrode set 42 have been tested ( 116 ).
  • clinician programmer 20 may select a different first anode or first cathode based on input received from the clinician.
  • clinician programmer 20 ends the electrode search algorithm ( 118 ), and may display a list of tested combinations as described above.
  • clinician programmer 20 may create a bracket of untested combinations that the clinician may elect to include in neurostimulation therapy programs.
  • the bracket may consist of any number of electrode combinations, and may comprise the next n combinations that would have been tested according to the electrode combination search algorithm.
  • clinician programmer 20 may allow clinician to spend less time searching for desirable electrode combinations.
  • the programs created using the bracket combinations may enable desirable neurostimulation therapy similar to that provided a program created with the most recently tested combination, and may be provided to patient 12 so that patient 12 can experiment with the bracket programs outside of the clinic.
  • FIGS. 6A-6K are diagrams illustrating example matrices 120 - 220 that illustrate positions within exemplary electrode sets.
  • FIGS. 6A-B , D-E and H-J illustrate two-by-eight matrices 120 , 130 , 150 , 160 , 190 , 200 and 210 that identify positions within a two-by-eight side-by-side electrode set, such as electrode set 42 .
  • FIGS. 6C , F-G and K illustrate one-by-eight matrices 140 , 170 , 180 and 220 that identify positions within a one-by-eight or two-by-four in-line electrode set. More particularly, FIGS. 6A-6K illustrate orders in which clinician programmer 20 may select electrodes within such electrode sets to test according to electrode combination search algorithms consistent with the invention, each position within a matrix indicating an electrode within an electrode set.
  • Matrices 120 , 130 and 140 of FIGS. 6A-C illustrate orders in which clinician programmer 20 may select electrodes to test as the first cathode.
  • the “ ⁇ ” symbol in each of matrices 120 , 130 and 140 indicates the initial position, i.e., the first electrode tested as the first cathode. Additional electrodes may be tested as a first cathode in the numeric orders illustrated, which illustrate examples of testing orders that are based on decreasing proximity to the initial position.
  • Matrices 150 , 160 , 170 and 180 of FIGS. 6D-G illustrate orders in which clinician programmer 20 may select electrodes to test with an identified first cathode as the first anode.
  • the “ ⁇ ” symbol in each of matrices 150 , 160 , 170 and 180 indicates the identified position of the first cathode.
  • the “+” symbol in each of matrices 150 , 160 , 170 and 180 indicates the position of an electrode already tested with the first cathode as the first anode during the process of identifying the first cathode.
  • Electrodes of an electrode set corresponding to one of matrices 150 , 160 , 170 and 180 may be tested as a first anode in the numeric orders illustrated, which illustrate examples of testing orders that are based on decreasing proximity to the identified first cathode.
  • Matrices 190 , 200 , 210 and 220 of FIGS. 6H-K illustrate orders in which clinician programmer 20 may select electrodes to test with an identified first cathode/first anode pair as an additional anode.
  • the “ ⁇ ” symbol in each of matrices 190 , 200 , 210 and 220 indicates the identified position of the first cathode.
  • the “+” symbol in each of matrices 190 , 200 , 210 and 220 indicates the identified position of the first anode.
  • Clinician programmer 20 may test other undesignated electrodes of an electrode set corresponding to one of matrices 190 , 200 , 210 and 220 as an additional anode in the numeric orders illustrated, which illustrate examples of testing orders that are based on decreasing proximity to the identified first cathode.
  • clinician programmer 20 may test only a subset of the undesignated electrodes of an electrode set. Specifically, clinician programmer 20 may avoid testing electrodes as an additional anode that would provide substantially the same current flow as the first cathode/first anode pair due to the orientation of the additional anode and the first cathode/first anode pair. By testing only a subset of the undesignated electrodes and avoiding redundant combinations, clinician programmer 20 may further shorten the time required of the clinician to identify desirable electrode combinations.
  • clinician programmer 20 may test electrodes within any type of electrode configuration. Further, configurations that include multiple additional anodes, or one or more additional cathodes may be tested. Whenever a cathode or anode is added, testing may be limited to a subset of undesignated electrodes in order to avoid redundant combinations.
  • FIG. 7 is a flow diagram illustrating an example method that may be employed by clinician programmer 20 to test an electrode combination according to the invention. Specifically, FIG. 7 illustrates a method that may be employed by clinician programmer 20 each time a new electrode is tested as a first or additional cathode, or first or additional anode. In other words, FIG. 7 illustrates a method that may be employed by clinician programmer 20 each time clinician programmer 20 identifies a new electrode combination to test ( 230 ).
  • Clinician programmer 20 controls IMD 14 to test the combination by controlling IMD 14 to deliver neurostimulation therapy via the combination.
  • the clinician may select desired starting points for pulse amplitude, rate and width, and clinician programmer 20 may ramp the amplitude from the starting point at a first rate of amplitude increase ( 232 ).
  • Clinician programmer 20 may increase the amplitude in, for example, a linear or step-wise fashion.
  • the clinician or patient 12 may control the rate of amplitude increase.
  • the clinician or patient 12 stops the ramping of the amplitude when the stimulation causes discomfort, or other undesirable side effects ( 234 ).
  • Clinician programmer 20 may reduce the amplitude at the time the ramp is stopped by some amount, e.g., a percentage, and ramps the amplitude again in order to allow the clinician and/or patient 12 to identify the amplitude that provides the best neurostimulation therapy ( 236 , 238 ). This second time, clinician programmer 20 may ramp the amplitude at a slower rate of amplitude increase in order to facilitate identification of the point where best neurostimulation is achieved. Again, in some embodiments, the clinician or patient 12 may control the amplitude.
  • some amount e.g., a percentage
  • Clinician programmer 20 stores the amplitude at the time when the best neurostimulation therapy is indicated by the clinician and/or patient 12 , and rating information for the combination ( 240 , 242 ).
  • the clinician and/or patient 12 may provide rating information, e.g., a numerical value for one or more metrics for rating the combination, which relates to the efficacy enabled by the combination or the side effects resulting from use of the combination, or both.
  • the clinician may use rating information and/or the amplitude values stored for each tested combination to identify desirable combinations.
  • the combinations and their associated information and values may be presented in a list that may be ordered according to the information, the values, or a combination of the two.
  • the amplitude value may, for example, be used to distinguish between tested combinations with similar ratings based on the power that must be consumed in order for each combination to enable desirable neurostimulation therapy.
  • FIG. 8 is a flow diagram illustrating an example method that may be employed by clinician programmer 20 to replicate a selected neurostimulation therapy program.
  • the clinician or patient 12 may use clinician programmer 20 to test variety of values of other neurostimulation therapy program parameters, such as pulse amplitude, pulse rate, pulse width and duty cycle, with the identified electrode combinations, i.e., to test a variety of neurostimulation therapy programs 60 .
  • Clinician programmer 20 may collect rating information for each of the tested neurostimulation therapy programs, e.g., information indicating efficacy, side effects, or power consumption of each of the programs.
  • Clinician programmer 20 identifies a plurality of desirable neurostimulation therapy programs 60 from among those tested during the programming session for use in controlling delivery of neurostimulation therapy to patient 12 by IMD 14 , e.g., receives selections from among programs 60 made by the clinician via user interface 52 ( 250 ).
  • Clinician programmer 20 selects one of the neurostimulation therapy programs identified during the programming session, e.g., receives a selection of one of the programs made by the clinician, and receives a replication command from the clinician ( 252 , 254 ). In response to the replication command, clinician programmer 20 generates one or more copies of the selected neurostimulation therapy program ( 256 ). Clinician programmer 20 provides the selected neurostimulation therapy program 60 and the one or more copies to at least one of IMD 14 and patient programmer 24 , where they may be individually selected and used to control delivery of therapy by IMD 14 ( 258 ).
  • clinician programmer 20 may allow a clinician to quickly generate a plurality of similarly desirable programs for selection and use by patient 12 .
  • clinician programmer 20 may change one or more of the parameters of the selected program. For example, one or more of pulse amplitude, pulse width, pulse rate, or duty cycle may be changed to provide a plurality of similar programs with various intensities and battery consumption rates, e.g., clinician programmer may provide a “high intensity” and “low intensity” version of a selected program.
  • clinician programmer 20 may allow patient 12 to select a program that addresses a current symptom level, e.g., pain level which may vary based on patient posture, activity or time of day, with a comparatively lower rate of battery consumption.
  • clinician programmer 20 may associate the selected program and the copies with respective postures, activities, times of day, symptom intensity states, or program side effect states, e.g., may label a selected program and a copy as “sitting” and “standing,” “active” and “inactive,” “daytime” and “nighttime,” or “high” and “low,” respectively.
  • patient 12 may be unaware of the differences between the intensities of the program and the copies, and either IMD 14 or patient programmer 26 may collect information regarding the use of the program and the copies to determine whether patient 12 will accept a program with a lower intensity and battery consumption rate.
  • clinician programmer 20 may provide one or more copies that are identical to the selected program, and patient 12 may adjust one or more parameters of the copies to create similarly desirable programs with different intensities and battery consumption rates to, for example, address different symptom levels associated with different postures or activities.
  • Clinician programmer 20 may change one or more parameters of a program when creating a copy of the program by a user-selected amount or a predetermined amount. For example, in situations in which desirable programs are identified when patient 12 is in a sitting posture, clinician programmer 20 may generate a copy of at least one of the programs to be a “standing” version of the selected program. Clinician programmer 20 may change an intensity related parameter of the selected program, e.g., amplitude, by a predetermined amount that is substantially equal to the difference between an average pulse amplitude used by patients when sitting and an average pulse amplitude used by patients when standing. The predetermined amount may be determined experimentally, and may be stored in memory 54 such that it is available to processor 50 .
  • the predetermined amount may be determined experimentally, and may be stored in memory 54 such that it is available to processor 50 .
  • clinician programmer 20 may generate a “high intensity” and/or a “low intensity” version of a program based on stimulation thresholds identified during the programming session.
  • a pain threshold and a perception threshold are examples of stimulation thresholds that may be identified during a programming session.
  • Clinician programmer 20 may identify the values of one or more intensity related program parameters, such as pulse amplitude and pulse width, that result in identification of these thresholds by patient 12 , and may change parameter values when generating high intensity or low intensity copies of a program based on the parameter values associated with the thresholds.
  • clinician programmer 20 may generate a high intensity copy of a selected program such that one or more program parameter values of the copy are substantially equal to the values associated with a pain threshold, and may generate a low intensity copy of a selected program such that one or more program parameter values of the copy are substantially equal to the values associated with the perception threshold.
  • FIG. 9 is a flow diagram illustrating an example method that may be employed by clinician programmer 20 to automatically generate program groups based on program categories associated with neurostimulation therapy programs.
  • Clinician programmer 20 identifies a plurality of desirable neurostimulation therapy programs 60 from among those tested during a programming session, e.g., receives selections from among programs 60 made by the clinician via user interface 52 ( 260 ).
  • Clinician programmer 20 then associates each of the plurality of identified neurostimulation therapy programs with one or more of a plurality of program categories ( 262 ), and automatically generates a plurality of program groups, e.g., automatically assigns programs to groups, based on their associated program categories ( 262 , 264 ).
  • Clinician programmer 20 may automatically generate the program groups in response to receiving a program group generation command from the clinician via user interface 52 .
  • each of the program categories is related to a characteristic of neurostimulation therapy programs.
  • Clinician programmer 20 may generate program groups to include programs associated with different categories, e.g., programs associated with different paresthesia or electrode locations, or may generate program groups to include programs associated with same category, e.g., programs associated with same intensity or same posture.
  • clinician programmer 20 combinatorially generates program groups from a set neurostimulation therapy programs identified during a programming session.
  • clinician programmer 20 may automatically generate a plurality of program groups by generating multiple combinations of neurostimulation therapy programs that comply with one or more criteria related to program categories.
  • clinician programmer 20 may order the programs within each category according to rating information, e.g., collected during a neurostimulation programming session, and may maintain a preference for use of more “highly” rated programs when combining programs to create groups, e.g., may create program groups based on both the program categories and the rating information. For example, clinician programmer 20 may exclude “poorly” rated programs from program groups, or may assign higher rated programs to groups more frequently than lower rated programs.
  • rating information e.g., collected during a neurostimulation programming session
  • clinician programmer 20 may take the form of any type of computing device, such as a laptop or desktop computer, may access resources, such as memory 54 , via a computer network, such as a LAN, WAN, or the World Wide Web.
  • clinician programmer 20 may include a plurality of computing devices, which may communicate to provide the functionality ascribed to clinician programmer 20 herein via a computer network.
  • clinician programmer 20 may additionally or alternatively be associated with patient 12 , i.e., act as a patient programmer.
  • patient 12 may simply interact with programmer 20 in place of the clinician for some or all of the electrode combination and neurostimulation therapy program identification process.
  • patient 12 may perform parts of the combination identification process without being supervised by the clinician, e.g., away from the clinic, using patient programmer 26 .
  • neurostimulation programs selected for replication and/or combination into program groups need not be programs identified during a neurostimulation programming session. For example, programs retrieved from a trial neurostimulator or patient programmer 26 , such as programs that are the result of patient adjustment parameters over a trialing period, may be replicated and/or combined into program groups. Similarly, programs may be retrieved from IMD 14 or patient programmer 26 during a follow up visit, and selected for replication and/or program group generation based on usage or rating information stored by IMD 14 or patient programmer 26 .
  • the clinician may store neurostimulation therapy programs that have been identified as generally efficacious, e.g., during treatment of other patients, in memory 56 or another memory accessible by clinician programmer 20 , and may select such programs for replication and/or combination into program groups.

Abstract

A programmer allows a clinician to identify desirable combinations of electrodes from within an electrode set implanted in a patient that enable delivery of desirable neurostimulation therapy by an implantable medical device. The clinician may create neurostimulation therapy programs that include identified desirable electrode combinations. In some embodiments, the clinician may use the programmer to select a program, such as a program identified during a neurostimulation programming session, and direct the programmer to replicate the selected program. The programmer may change one or more parameters of the selected program, such as pulse amplitude or duty cycle, when generating the copy of the selected program. In some embodiments, the programmer may associate each of a plurality of programs identified during a neurostimulation therapy programming session with one or more program categories, and may automatically generate program groups that include two or more of the programs based on the program categories.

Description

This application is a continuation-in-part of U.S. application Ser. No. 10/424,194, filed Apr. 25, 2003, now U.S. Pat. No. 7,463,928 the entire content of which is incorporated herein by reference.
TECHNICAL FIELD
The invention relates to neurostimulation therapy and, more particularly, to generation of therapy programs and program groups used for delivery of neurostimulation therapy to a patient.
BACKGROUND
Implantable medical devices may be used to deliver neurostimulation therapy to patients to treat a variety of symptoms or conditions such as chronic pain, tremor, Parkinson's disease, epilepsy, incontinence, or gastroparesis. An implantable medical device may deliver neurostimulation therapy via leads that include electrodes located proximate to the spinal cord, pelvic nerves, or stomach, or within the brain of a patient. In general, the implantable medical device delivers neurostimulation therapy in the form of electrical pulses.
A clinician may select values for a number of programmable parameters in order to define the neurostimulation therapy to be delivered to a patient. For example, the clinician may select an amplitude, which may be a current or voltage amplitude, and pulse width for a stimulation waveform to be delivered to the patient, as well as a rate at which the pulses are to be delivered to the patient. The clinician may also select as parameters particular electrodes within an electrode set to be used to deliver the pulses, and the polarities of the selected electrodes. A group of parameter values may be referred to as a program in the sense that they drive the neurostimulation therapy to be delivered to the patient.
The process of selecting values for the parameters that provide adequate results can be time consuming, and may require a great deal of trial and error before a “best” program is discovered. The “best” program may be a program that is better in terms of clinical efficacy versus side effects experienced and power consumption than other programs tested. As a portion of the overall parameter selection process, the process of selecting electrodes and the polarities of the electrodes can be particularly time-consuming and tedious. The clinician may need to test all possible combinations of electrodes within the set implanted in the patient, or a significant portion thereof, in order to identify a “best” combination of electrodes and their polarities.
In some cases, the clinician may test combinations by manually specifying each combination to test based on intuition or some idiosyncratic methodology, and recording notes on the efficacy and side effects of each combination after delivery of stimulation via that combination. In this manner, the clinician is able to later compare and select from the tested combinations. As an example illustrating the magnitude of such a task, implantable medical devices commonly deliver spinal cord stimulation therapy (SCS) to a patient via two leads that include eight electrodes per lead and provide well over one million potential electrode combinations.
SUMMARY
In general, the invention is directed to techniques that may be employed by a programming device to allow a clinician or patient to identify combinations of electrodes from within an electrode set implanted in a patient that enable delivery of desirable neurostimulation therapy by an implantable medical device. The programmer may execute an electrode combination search algorithm to select combinations of electrodes to test in a non-random order. By selecting combinations in a non-random order, the programmer may allow the clinician or patient to more quickly identify desirable electrode combinations.
According to algorithms consistent with the invention, the programmer may identify a position of a first cathode electrode for subsequent combinations, and then select electrodes from the electrode set to test with the first cathode as anodes or additional cathodes based on the proximity of the electrodes to the first cathode. The programmer may identify a first position within the electrode set, which may be a central position within the electrode set, and control the implantable medical device to test the electrode located at that position as the first cathode. The programmer may then test additional electrodes from within the set as the first cathode in an order based on proximity to the first cathode.
The programmer may receive input from the clinician or patient indicating which tested electrode is the first cathode, and then control the implantable medical device to test other electrodes of the set in combination with the first cathode. Undesignated electrodes may be tested as anodes and additional cathodes in an order based on proximity to the first cathode. In some cases, only a subset of the undesignated electrodes may be tested to avoid testing redundant electrode combinations, i.e., electrode combinations that would produce substantially the same current flow as an electrode combination already tested.
The programmer may store information for each combination tested, and the information may facilitate the identification of desirable electrode combinations by the clinician. For example, the programmer may present a list of tested combinations and their associated information, and the list may be ordered according to the information. The clinician may create neurostimulation therapy programs that include identified desirable program combinations.
For example, after identifying a plurality of desirable electrode combinations, the clinician or patient may use the programmer to test a variety of values of other neurostimulation therapy program parameters, such as pulse amplitude, pulse rate, pulse width and duty cycle, with the identified electrode combinations, i.e., to test a variety of neurostimulation therapy programs. The programmer may collect rating information for each of the tested neurostimulation therapy programs. The clinician may use the programmer to identify a plurality of desirable neurostimulation therapy programs from among those tested during the programming session for use in controlling delivery of neurostimulation therapy to the patient by the implantable medical device.
In some embodiments, the programmer provides a neurostimulation therapy program replication function. In such embodiments, the programmer selects one of the neurostimulation therapy programs identified during the programming session, e.g., receives a selection of one of the programs made by the clinician, and receives a replication command from the clinician. In response to the replication command, the programmer generates one or more copies of the selected neurostimulation therapy program. In some embodiments, as part of generation of a copy, the programmer may change one or more of the parameters of the selected program, e.g., pulse amplitude, pulse rate, pulse width, duty cycle, or electrode combination. In other embodiments, the programmer may provide one or more copies that are identical to the selected program, and the patient or clinician may adjust one or more parameters of the copies.
In some embodiments, the implantable medical device delivers therapy to the patient according to program groups, i.e., groups of two or more neurostimulation therapy programs. The implantable medical device may deliver the two or more programs of a program group to the patient substantially simultaneously. For example, the implantable medical device may deliver each neurostimulation therapy pulse according to a different one of the plurality of programs of a program group.
In such embodiments, the programmer may automatically generate one or more program groups that include two or more of a plurality of neurostimulation programs identified as desirable during programming session. In particular, the programmer may associate each of a plurality of identified neurostimulation therapy programs with one or more of a plurality of program categories, and may generate the groups, e.g., assign programs to groups, based on their associated program categories. The programmer may automatically generate the program groups in response to receiving a program group generation command from the clinician.
Each of the program categories is related to a characteristic of neurostimulation therapy programs. For example, the programmer may categorize a neurostimulation therapy program by paresthesia location, e.g., left-side, right-side, or bilateral, or based on the location of electrodes included within its electrode combination. Generally, in embodiments in which neurostimulation therapy programs are categorized by paresthesia or electrode location, the programmer may generate a program group to include programs associated with different categories, e.g., programs associated with different paresthesia or electrode locations. A program group that includes programs associated with different paresthesia or electrode locations may be able to, for example, address complex pain patterns, and avoid conflicts that can arise when sequential pulses are delivered according to different programs via the same electrodes.
As other examples, the programmer may categorize a neurostimulation therapy program according to stimulation intensity, e.g., high, medium or low, according to posture, e.g., standing or sitting, according to patient activity, e.g., running or sitting, according to time of day, e.g., daytime or evening, according to symptom intensity, e.g., high or low, or according to stimulation side effects, e.g., high or low. Generally, in embodiments in which neurostimulation therapy programs are categorized by intensity, posture, activity, time of day, symptom intensity, or side effects, the programmer may generate a program group to include programs associated with the same category, e.g., programs associated with the same intensity, posture, activity, time of day, symptom intensity, or side effects. A program group that includes programs associated with the same stimulation intensity level, symptom intensity level, posture, or activity, for example, may be selected by the patient to address a current symptom level, or when the patient assumes a particular posture or undertakes a particular activity.
In exemplary embodiments, the programmer combinatorially generates program groups from a set of neurostimulation therapy programs identified during a programming session. In other words, the programmer may automatically generate a plurality of program groups by generating multiple combinations of neurostimulation therapy programs that comply with one or more criteria related to program categories. In some embodiments, the programmer may order the programs within each category according to rating information, e.g., collected during a neurostimulation programming session, and may maintain a preference for use of more “highly” rated programs when combining programs to create groups, e.g., may create program groups based on both the program categories and the rating information. For example, the programmer may exclude “poorly” rated programs from program groups, or may assign higher rated programs to groups more frequently than lower rated programs.
In one embodiment, the invention is directed to a method in which a first electrode of a set of electrodes implanted in a patient is selected to be included in a combination of electrodes for use in delivery of neurostimulation to the patient. The first electrode may be a cathode for the combination. A sequence of additional electrodes of the set to test for inclusion in the combination is automatically selected according to locations of the additional electrodes relative to the first electrode. The additional electrodes may be tested for inclusion of one of the additional electrodes as an anode for the combination.
In another embodiment, the invention is directed to a computer-readable medium containing instructions. The instructions cause a programmable processor to select a first electrode of a set of electrodes implanted in a patient to include in a combination of electrodes for use in delivery of neurostimulation to the patient. The instructions also cause a processor to automatically select a sequence of additional electrodes within the set to test for inclusion in the combination according to locations of the additional electrodes relative to the first electrode.
In another embodiment, the invention is directed to a device that includes a processor. The processor selects a first electrode of a set of electrodes implanted in a patient to include in a combination of electrodes for delivery of neurostimulation therapy to the patient. The processor also automatically selects a sequence of additional electrodes to test for inclusion in the combination according to locations of the additional electrodes relative to the first electrode. The device may be a programming device associated with one of a clinician and the patient.
In another embodiment, the invention is directed to a method in which a search algorithm is executed to control an implantable medical device to test combinations of electrodes in an order that is based on the proximity of the electrodes of the combinations to a central position within the set. Information identifying at least one of the tested combinations is stored as part of a neurostimulation therapy program that defines neurostimulation therapy to be delivered to the patient by the implantable medical device.
In another embodiment, the invention is directed to a method in which a neurostimulation therapy program that includes a set of neurostimulation therapy parameters is selected, and a replication command is received from a user. A copy of the selected neurostimulation therapy program is generated in response to the replication command, and the selected neurostimulation therapy program and the copy are provided to at least one of a programming device or a medical device. A selected one or more of the neurostimulation therapy program and the copy controls delivery of neurostimulation therapy to a patient by the medical device.
In another embodiment, the invention is directed to a device that includes a user interface, a communication circuit, and a processor. The processor selects a neurostimulation therapy program that includes a set of neurostimulation therapy parameters, receives a replication command from a user via the user interface, generates a copy of the selected neurostimulation therapy program in response to the replication command, and provides the selected neurostimulation therapy program and the copy to at least one of a programming device or a medical device via the communication circuit. A selected one or more of the neurostimulation therapy program and the copy controls delivery of neurostimulation therapy to a patient by the medical device.
In another embodiment, the invention is directed to a computer-readable medium comprising instructions. The instructions cause a programmable processor to select a neurostimulation therapy program that includes a set of neurostimulation therapy parameters, receive a replication command from a user, generate a copy of the selected neurostimulation therapy program in response to the replication command, and provide the selected neurostimulation therapy program and the copy to at least one of a programming device or a medical device. A selected one or more of the neurostimulation therapy program and the copy controls delivery of neurostimulation therapy to a patient by the medical device.
In another embodiment, the invention is directed to a method in which a plurality of neurostimulation therapy programs are identified during a neurostimulation therapy programming session, and each of the identified neurostimulation therapy programs is associated with at least one of a plurality of program categories. Each of the program categories is related to a characteristic of at least one of the identified neurostimulation therapy programs. A plurality of program groups is automatically generated based on the program categories, each of the program groups including at least two of the identified neurostimulation therapy programs.
In another embodiment, the invention is directed to a device that includes a memory and a processor. The memory stores a plurality of neurostimulation therapy programs identified during a neurostimulation therapy programming session. The processor associates each of the identified neurostimulation therapy programs with at least one of a plurality of program categories, and automatically generates a plurality of program groups based on the program categories. Each of the program categories is related to a characteristic of at least one of the identified neurostimulation therapy programs, and each of the program groups including at least two of the identified neurostimulation therapy programs
In another embodiment, the invention is directed to a computer-readable medium comprising instructions. The instructions cause a programmable processor to identify a plurality of neurostimulation therapy programs during a neurostimulation therapy programming session, associate each of the identified neurostimulation therapy programs with at least one of a plurality of program categories, and automatically generate a plurality of program groups based on the program categories. Each of the program categories is related to a characteristic of at least one of the identified neurostimulation therapy programs, and each of the program groups including at least two of the identified neurostimulation therapy programs.
The invention may provide a number of advantages. For example, the invention may allow a clinician to more quickly identify desirable electrode combinations, reducing the overall amount of time the clinician spends programming neurostimulation therapy for a patient. In contrast to existing neurostimulation programming systems that present electrode combinations in a random order and idiosyncratic search methodologies employed by clinicians, programmer according to the invention may select electrode combinations in a systematic manner to test in an order such that electrode combinations that are more likely to enable desirable therapy are selected earlier in the search. Consequently, the clinician may be able to end the search before all potential electrode combinations have been tested if one or more desirable combinations have already been identified.
Even if a clinician elects to test all potential electrode combinations, e.g., if the electrode set is small enough to make testing all electrode combinations practical, the invention may reduce the time required to identify desirable electrode combinations by automating selection of each new combination to test. The invention may also avoid testing redundant combinations, i.e., combinations that are substantially equivalent to combinations already tested. Avoiding redundant combinations may further reduce the amount of time required for the search.
Additionally, the invention may improve the search process by collecting amplitude information, and rating information that is entered by the clinician or patient, for each combination tested. A programmer according to the invention may present a list of tested electrode combinations to the clinician, ordered according to one or both of the amplitude and rating information, allowing the clinician to more easily identify and select desirable combinations. A bracket of untested electrode combinations that are similar to identified electrode combinations may be used to create programs that are provided to the patient. Providing bracket programs to the patient allows the patient to experiment with the programs to “finely tune” the neurostimulation therapy provided by the implantable medical device without requiring the clinician to be involved.
By replicating a neurostimulation therapy program that has been identified as desirable, a programmer according to the invention may allow a clinician to quickly generate a plurality of similarly desirable programs for selection, modification and use by a patient. In embodiments in which the programmer changes one or more of pulse amplitude, pulse width, pulse rate, or duty cycle, the programmer may provide a plurality of similar programs with various intensities and battery consumption rates, e.g., a high intensity and low intensity version of a selected program. By providing a plurality of programs that are replicated with parameters that are changed in this manner, the programmer may enable selection of a program that addresses a current symptom level, e.g., a pain level which may vary based on patient posture, activity or time of day, with a comparatively lower rate of battery consumption. In some embodiments, the programmer may associate the selected program and the copies with respective postures, activities, times of day, symptom states, or side effect states, e.g., may label a selected program and a copy as “sitting” and “standing,” “high” and “low,” or “daytime” and “nighttime,” respectively. In embodiments in which the programmer generates identical copies of a selected neurostimulation therapy program, the patient may use a patient programmer to adjust parameters of program copies to create similarly desirable programs with different intensities and battery consumption rates to, for example, address different symptom levels associated with different postures or activities.
As another example, by providing for automatic generation of program groups, a programmer according to the invention may be able to quickly provide a clinician with a plurality of program groups that include combinations of neurostimulation therapy programs. Moreover, use of program categories may allow the programmer to generate programs groups that include desirable and/or logical combinations of programs.
The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
BRIEF DESCRIPTION OF DRAWINGS
FIG. 1 is a diagram illustrating an example system for programming and delivering neurostimulation therapy.
FIG. 2 is a diagram illustrating an example electrode set that may be implanted within the patient.
FIG. 3 is a block diagram illustrating an example programming device that allows a user to identify desirable electrode combinations for neurostimulation therapy programs.
FIG. 4 is a flow diagram illustrating an example method that may be employed by a programming device to select and execute an electrode combination search algorithm according to the invention.
FIG. 5A and 5B are flow diagrams illustrating an example electrode combination search algorithm that may be executed by a programming device.
FIGS. 6A-6K are diagrams illustrating example matrices that illustrate positions within exemplary electrode set configurations and orders in which electrodes within such electrode sets may be tested according to electrode combination search algorithms consistent with the invention.
FIG. 7 is a flow diagram illustrating an example method that may be employed by a programming device to test an electrode combination according to the invention.
FIG. 8 is a flow diagram illustrating an example method that may be employed by a programming device to replicate a selected neurostimulation therapy program.
FIG. 9 is a flow diagram illustrating an example method that may be employed by a programming device to automatically generate program groups based on program categories associated with neurostimulation therapy programs.
DETAILED DESCRIPTION
FIG. 1 is a diagram illustrating an example system 10 for programming neurostimulation therapy for and delivering neurostimulation therapy to a patient 12. System 10 includes an implantable medical device 14 that delivers neurostimulation therapy to patient 12. IMD 14 may be an implantable pulse generator, and may deliver neurostimulation therapy to patient 12 in the form of electrical pulses. In the illustrated example system 10, IMD 14 delivers neurostimulation therapy to patient 12 via leads 16A and 16B (collectively “leads 16”). Leads 16 may, as shown in FIG. 1, be implanted proximate to the spinal cord 18 of patient 12, and IMD 14 may deliver spinal cord stimulation (SCS) therapy to patient 12 in order to, for example, reduce pain experienced by patient 12.
However, the invention is not limited to the configuration of leads 16 shown in FIG. 1 or the delivery of SCS therapy. For example, one or more leads 16 may extend from IMD 14 to the brain (not shown) of patient 12, and IMD 14 may deliver deep brain stimulation (DBS) therapy to patient 12 to, for example, treat tremor or epilepsy. As further examples, one or more leads 16 may be implanted proximate to the pelvic nerves (not shown) or stomach (not shown), and IMD 14 may deliver neurostimulation therapy to treat incontinence or gastroparesis. Moreover, the invention is not limited to systems in which an IMD delivers neurostimulation therapy to patient 12. For example, in some embodiments of the invention, an external neurostimulator, e.g., a transcutaneuous electrical stimulation (TENS) device, or a trial neurostimulator may deliver neurostimulation therapy to patient 12.
IMD 14 delivers neurostimulation therapy to patient 12 according to one or more neurostimulation therapy programs. A neurostimulation therapy program may include values for a number of parameters, and the parameter values define the neurostimulation therapy delivered according to that program. In embodiments where IMD 14 delivers neurostimulation therapy in the form of electrical pulses, the parameters may include pulse voltage or current amplitudes, pulse widths, pulse rates, duty cycles and the like. Further, each of leads 16 includes electrodes (not shown in FIG. 1), and the parameters for a program may include information identifying which electrodes have been selected for delivery of pulses according to the program, and the polarities of the selected electrodes.
A selected subset of the electrodes located on leads 16 and the polarities of the electrodes of the subset collectively define an “electrode combination.” Electrode combinations refer to combinations of single or multiple cathode electrodes and single or multiple anode electrodes. Stimulation current flows between the cathodes and anodes for delivery of neurostimulation therapy.
System 10 also includes a clinician programmer 20. Clinician programmer 20 may, as shown in FIG. 1, be a handheld computing device. Clinician programmer 20 includes a display 22, such as a LCD or LED display, to display information to a user. Clinician programmer 20 may also include a keypad 24, which may be used by a user to interact with programmer 20. In some embodiments, display 22 may be a touch screen display, and a user may interact with clinician programmer 20 via display 22. A user may also interact with clinician programmer 20 using peripheral pointing devices, such as a stylus or mouse. Keypad 24 may take the form of an alphanumeric keypad or a reduced set of keys associated with particular functions. A clinician (not shown) may use clinician programmer 20 to program neurostimulation therapy for patient 12, as will be described in greater detail below.
System 10 also includes a patient programmer 26, which also may, as shown in FIG. 1, be a handheld computing device. Patient 12 may use patient programmer 26 to control the delivery of therapy by IMD 14. For example, using patient programmer 26, patient 12 may select a current neurostimulation therapy program or group of neurostimulation therapy programs from among the programs or program groups preprogrammed by the clinician, or may adjust one or more parameters of a therapy program or program group.
0049 Patient programmer 26 may also include a display 28 and a keypad 30 to allow patient 12 to interact with patient programmer 26. In some embodiments, display 28 may be a touch screen display, and patient 12 may interact with patient programmer 26 via display 28. Patient 12 may also interact with patient programmer 26 using peripheral pointing devices, such as a stylus, mouse, or the like.
However, clinician and patient programmers 20, 26 are not limited to the hand-held computer embodiments illustrated in FIG. 1. Programmers 20, 26 according to the invention may be any sort of computing device. For example, a programmer 20, 26 according to the invention may a tablet-based computing device, a desktop computing device, or a workstation.
IMD 14, clinician programmer 20 and patient programmer 26 may, as shown in FIG. 1, communicate via wireless communication. Clinician programmer 20 and patient programmer 26 may, for example, communicate via wireless communication with IMD 14 using radio frequency (RF) telemetry techniques known in the art. Clinician programmer 20 and patient programmer 26 may communicate with each other using any of a variety of local wireless communication techniques, such as RF communication according to the 802.11 or Bluetooth specification sets, infrared communication according to the IRDA specification set, or other standard or proprietary telemetry protocols.
Clinician programmer 20 and patient programmer 26 need not communicate wirelessly, however. For example, programmers 20 and 26 may communicate via a wired connection, such as via a serial communication cable, or via exchange of removable media, such as magnetic or optical disks, or memory cards or sticks. Further, clinician programmer 20 may communicate with one or both of IMD 14 and patient programmer 26 via remote telemetry techniques known in the art, communicating via a local area network (LAN), wide area network (WAN), public switched telephone network (PSTN), or cellular telephone network, for example.
In some embodiments, the clinician may use clinician programmer 20 to create neurostimulation therapy programs. As part of the program creation process, clinician programmer 20 allows the clinician to identify electrode combinations that enable IMD 14 to deliver neurostimulation therapy that is desirable in terms of, for example, symptom relief, coverage area relative to symptom area, and side effects. Clinician programmer 20 may also allow the clinician to identify electrode combinations that enable IMD 14 to deliver effective neurostimulation therapy with desirable device performance characteristics, e.g., low battery consumption.
Clinician programmer 20 controls IMD 14 to test electrode combinations in order to allow a clinician to identify desirable combinations in an efficient manner. As will be described in greater detail below, clinician programmer 20 may select electrode combinations to test based on an electrode combination search algorithm. In particular, according to such an algorithm, clinician programmer 20 may first control IMD 14 to test one or more electrodes to identify the electrode which will act as a first cathode electrode, and then control IMD 14 to test combinations that include the first cathode in an order that is based on the proximity of other electrodes in the combination to the first cathode.
By controlling IMD 14 to test electrode combinations in such an order, clinician programmer 20 may allow the clinician to more quickly identify desirable electrode combinations, reducing the overall amount of time the clinician spends programming neurostimulation therapy for patient 12. In contrast to existing neurostimulation programming systems that present electrode combinations in a random order and idiosyncratic search methodologies employed by clinicians, clinician programmer 20 may select electrode combinations to test in an order such that electrode combinations that are more likely to enable desirable therapy are selected earlier in the search. Consequently, the clinician may be able to end the search before all potential electrode combinations have been tested if one or more desirable combinations have already been identified, saving the amount clinician and patient time required to achieve an efficacious electrode combination.
Even if the clinician elects to test all potential electrode combinations, e.g., if the electrode set is small enough to make testing all electrode combinations practical, programmer 20 may reduce the time required to identify desirable electrode combinations by automating selection of each new combination to test. Additionally, clinician programmer 20 may improve the search process by collecting amplitude and rating information for each combination tested. As will be described in greater detail below, clinician programmer 20 may present a list of electrode combinations to the clinician, ordered according to one or both of the amplitude and rating information, allowing the clinician to more easily identify and select desirable combinations.
After identifying a plurality of desirable electrode combinations, the clinician or patient 12 may use clinician programmer 20 to test variety of values of other neurostimulation therapy program parameters, such as pulse amplitude, pulse rate, pulse width and duty cycle, with the identified electrode combinations, i.e., to test a variety of neurostimulation therapy programs. Clinician programmer 20 may collect rating information, e.g., information relating to efficacy, power consumption and/or side effects, from patient 12 for each of the tested neurostimulation therapy programs. Based on this testing, the clinician may use clinician programmer 20 to identify a plurality of desirable neurostimulation therapy programs from among those tested during the programming session for use in controlling delivery of neurostimulation therapy to patient 12 by IMD 14.
In some embodiments, as will be described in greater detail below, clinician programmer 20 provides a neurostimulation therapy program replication function. In such embodiments, clinician programmer 20 selects one of the neurostimulation therapy programs identified during the programming session, e.g., receives a selection of one of the programs made by the clinician, and receives a replication command from the clinician. In response to the replication command, clinician programmer 20 generates one or more copies of the selected neurostimulation therapy program.
By replicating a neurostimulation therapy program that has been identified as desirable, clinician programmer 20 may allow a clinician to quickly generate a plurality of similarly desirable programs for selection and use by patient 12. In some embodiments, as part of generation of a copy, clinician programmer 20 may change one or more of the parameters of the selected program. For example, pulse amplitude, pulse width, pulse rate, duty cycle, or a combination thereof may be changed to provide a plurality of similar programs with various intensities and battery consumption rates. As an example, clinician programmer 20 may provide a “high intensity” and “low intensity” version of a selected program.
By providing a plurality of programs that are replicated with parameters that are changed in this manner, clinician programmer 20 may allow patient 12,to select a program that addresses a current symptom level, e.g., pain level which may vary based on patient posture, activity, or time of day, with a comparatively lower rate of battery consumption. In some embodiments, clinician programmer 20 may associate the selected program and the copies with respective postures, activities, times of day, symptom intensity states, or program side effect states, e.g., may label a selected program and a copy as “sitting” and “standing,” “active” and “inactive,” “daytime” and “nighttime,” or “high” and “low,” respectively.
In other embodiments, patient 12 may be unaware of the differences between the intensities of the program and the copies, and either IMD 14 or patient programmer 26 may collect information regarding the use of the program and the copies to determine whether patient 12 will accept a program with a lower intensity and battery consumption rate. In some embodiments, clinician programmer 20 may provide one or more copies that are identical to the selected program, and patient 12 may adjust one or more parameters of the copies to create similarly desirable programs with different intensities and battery consumption rates to, for example, address different symptom levels associated with different postures, activities, or times of day.
In some embodiments, IMD 14 delivers therapy to patient 12 according to program groups, i.e., groups of two or more neurostimulation therapy programs. IMD 14 may deliver the two or more programs of a program group to patient 12 substantially simultaneously. For example, IMD 14 may deliver each neurostimulation therapy pulse according to a different one of the plurality of programs of a program group.
In such embodiments, clinician programmer 20 may automatically generate one or more program groups that include two or more of a plurality of neurostimulation programs identified as desirable during programming session. In particular, clinician programmer 20 may associate each of a plurality of identified neurostimulation therapy programs with one or more of a plurality of program categories, and generate the groups, e.g., assign programs to groups, based on their associated program categories. Clinician programmer 20 may automatically generate the program groups in response to receiving a program group generation command from the clinician.
Each of the program categories is related to a characteristic of neurostimulation therapy programs. For example, clinician programmer 20 may categorize a neurostimulation therapy program by paresthesia location, e.g., left-side, right-side, or bilateral, or based on the location of electrodes included within its electrode combination. Generally, in embodiments in which neurostimulation therapy programs are categorized by paresthesia or electrode location, clinician programmer 20 may generate a program group to include programs associated with different categories, e.g., programs associated with different paresthesia or electrode locations. A program group that includes programs associated with different paresthesia or electrode locations may be able to, for example, address complex pain patterns, and avoid conflicts that can arise when sequential pulses are delivered according to different programs via the same electrodes.
As other examples, clinician programmer 20 may categorize a neurostimulation therapy program according stimulation intensity, e.g., high, medium or low, according to posture, e.g., standing or sitting, according to patient activity, e.g., running or sitting, according to time of day, e.g., daytime or evening, according to symptom intensity, e.g., high or low, or according to stimulation side effects, e.g., high or low. Generally, in embodiments in which neurostimulation therapy programs are categorized by intensity, posture, activity, time of day, symptom intensity, or side effects, clinician programmer 20 may generate a program group to include programs associated with same category, e.g., programs associated with same intensity, posture, activity, time of day, symptom intensity, or side effects. A program group that includes programs associated with same stimulation intensity level, symptom intensity level, posture, or activity, for example, may be selected by patient 12 to address a current symptom level, or when patient 12 assumes a particular posture or undertakes a particular activity.
In order to control IMD 14 to test electrode combinations and neurostimulation therapy programs, clinician programmer 20 may, as indicated above, communicate with IMD 14 via telemetry techniques known in the art. For example, clinician programmer 20 may communicate with IMD 14 via an RF telemetry head (not shown). Information identifying desirable combinations of electrodes identified by the clinician may be stored as part of neurostimulation therapy programs. Neurostimulation therapy programs, program copies, and/or program groups, created or generated as described above, may be transmitted to IMD 14 via telemetry, and/or may be transmitted to patient programmer 26 via any wired or wireless communication technique. Once stored by one or both of IMD 14 and programmer 26, the programs and/or program groups may be available for selection, e.g., by patient 12, to control delivery of therapy by IMD 14.
FIG. 2 is a block diagram illustrating an example configuration of leads 16. In the example configuration, lead 16A includes electrodes 40A-H, and lead 16B includes electrodes 401-P. Electrodes 40A-P (collectively “electrodes 40”) may be ring electrodes.
Electrodes 40 collectively form an electrode set 42 implanted within patient 12. As shown in FIG. 2, electrode set 42 includes eight electrodes on each of the two leads 16, which, as shown in FIG. 1, are implanted such that they are substantially parallel to each other and spinal cord 18, on substantially opposite sides of spinal cord 18, at approximately the same height relative to spinal cord 18, and oriented such that the distal ends of leads 16 are higher relative to the spinal cord than the proximal ends of leads 16. Therefore, the illustrated configuration of electrode set 42 may be described as a two-by-eight, side-by-side, upwardly oriented configuration.
Such a configuration is commonly used to provide SCS therapy. However, programmer 20 may be used to identify desirable combinations of electrodes within electrode sets that are configured in any way, and used to provide any type neurostimulation therapy. For example, a single lead including four or eight electrodes, two leads including four electrodes per lead, in-line leads, and offset leads, all of which may be oriented in any manner relative to patient 12, provide electrode set configurations that may be searched by programmer 20.
IMD 14 (FIG. 1) may deliver neurostimulation via any combination of electrodes 40. IMD 14 may independently activate each electrode 40 of set 42 to act as a cathode or anode for a combination, and each combination will include at least one cathode and at least one anode. In some embodiments, a combination may include a single electrode 40 acting as the cathode, with a can of IMD 14, i.e., the IMD housing, acting as the anode for the combination.
In an electrode combination, electrons flow from the one or more electrodes acting as anodes for the combination to the one or more electrodes acting as cathodes for the combination. The current between anodes and cathodes may stimulate neurons between and proximate to the anodes and cathodes. Generally speaking, an electrode combination enables desirable neurostimulation therapy when current is delivered in a direction and with an intensity sufficient to stimulate specific neurons or a sufficient number of specific neurons to alleviate a symptom without causing unacceptable side effects. Further, an electrode combination enables desirable neurostimulation therapy when the symptom is alleviated without resorting to undesirably high pulse amplitudes.
As mentioned above, clinician programmer 20 selects individual electrodes 40 or electrode combinations to test to allow a clinician to identify desirable electrode combinations according to an electrode search algorithm. Clinician programmer 20 may select an appropriate search algorithm based on the configuration of electrode set 42, and may select electrodes 40 or electrode combinations based on the selected search algorithm. Clinician programmer 20 controls IMD 14 to test a selected electrode 40 or electrode combination by controlling IMD 14 to deliver neurostimulation via the selected electrode 40 or combination.
Clinician programmer 20 may first control IMD 14 to test one or more of electrodes 40 individually to identify the individual electrode or electrodes 40 which will act as a first cathode. Generally, a clinician implants leads 16 in a location such that the center of electrode set 42 is proximate to an area that the clinician believes should be stimulated in order to alleviate symptoms. Therefore, clinician programmer 20 may test electrodes 40 as the first cathode in an order such that electrodes 40 located centrally within electrode set 42, e.g., electrodes 40D-E and 40L-M illustrated in FIG. 2, are tested before peripherally located electrodes. If the clinician's estimation of the target region is inaccurate, clinician programmer 20 will continue to test individual electrodes 40 in such an order until one of the electrodes 40 that enables desirable neurostimulation therapy when activated as the first cathode is identified. Initially locating a first cathode provides a “coarse” optimization of electrode combinations, allowing clinician programmer 20 and the clinician to quickly identify the general area to which neurostimulation therapy should be delivered.
Clinician programmer 20 may then control IMD 14 to test electrode combinations that include the first cathode. Clinician programmer 20 may control IMD 14 to try different ones of electrodes 40 as the first anode in a pair with the first cathode, and may add additional anodes and/or cathodes. Clinician programmer 20 may control IMD 14 to test remaining electrodes 40 as first anodes, and additional anodes or cathodes, in an order that is based on the proximity of the remaining electrodes 40 to the electrode 40 acting as the first cathode for the electrode combination. The order may be based on decreasing proximity of the remaining electrodes 40 to the electrode acting as the first cathode, e.g., electrodes will be tested in order of increasing distance from the first cathode.
Generally, electrode combinations that include cathodes and anodes in closer proximity may be more likely to enable desirable neurostimulation therapy. Therefore, by testing electrode combinations in an order based on decreasing proximity of the other electrodes 40, clinician programmer 20 provides a “fine” optimization of electrode combinations, allowing the clinician to more quickly identify electrode combinations that enable more desirable neurostimulation therapy than the initial combination including the first cathode and the first location of the first anode. With this approach, the search for electrode combinations may proceed in a pattern or “orbit” in close proximity about an initially selected cathode or cathodes, and then extend outward into a more distant orbit as the search continues.
FIG. 3 is a block diagram illustrating an example configuration of clinician programmer 20. A clinician may interact with a processor 50 via a user interface 52 in order to identify electrode combinations, identify neurostimulation therapy programs, request neurostimulation therapy program replication, and request automatic program group generation, as described herein. User interface 52 may include display 22 and keypad 24, and may also include a touch screen or peripheral pointing devices as described above. Processor 50 may also provide a graphical user interface (GUI) via user interface 52 to facilitate interaction with a clinician. Processor 50 may include a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), discrete logic circuitry, or the like.
Clinician programmer 20 also includes a memory 54. Memory 54 may include program instructions that, when executed by processor 50, cause clinician programmer 20 to perform the functions ascribed to clinician programmer 20 herein. For example, processor 50 may execute a selected one of electrode combination search algorithms 56 stored within memory 54 to select individual electrodes 40 or electrode combinations to test to allow the clinician to identify desirable electrode combinations.
As will be described in greater detail below, processor 50 may collect information relating to tested electrode combinations, and store the information in memory 54 for later retrieval and review by the clinician to facilitate identification of desirable electrode combinations. Neurostimulation therapy programs 60 created by the clinician may be stored in memory 54, and information identifying electrode combinations selected by the clinician to be utilized for one of programs 60 may be stored as part of the program within memory 54. As described above, a plurality of desirable programs 60 may be identified, and may be replicated or assigned to program groups by processor 50. Memory 54 may include any volatile, non-volatile, fixed, removable, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), CD-ROM, hard disk, removable magnetic disk, memory cards or sticks, nonvolatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, and the like.
Processor 50 controls IMD 14 to test selected individual electrodes 40 or electrode combinations, by controlling IMD 14 to deliver neurostimulation therapy to patient 12 via the selected individual electrodes 40 or electrode combinations via a telemetry circuit 62. Similarly, processor 50 controls IMD 14 to test selected neurostimulation therapy programs 60, which include identified electrode combinations and other selected program parameters, by controlling IMD 14 to deliver neurostimulation therapy to patient 12 according to the selected program. Processor 50 may transmit programs 60 that are identified as desirable, copies of one or more such programs, and/or program groups that include two or more such programs to IMD 14 via telemetry circuit 62, or to patient programmer 26 via input/output circuitry 64. I/O circuitry 64 may include transceivers for wireless communication, appropriate ports for wired communication or communication via removable electrical media, or appropriate drives for communication via removable magnetic or optical media. Together, telemetry 62 and I/O circuitry 64 may form a communication circuit for clinician programmer 20.
FIG. 4 is a flow diagram illustrating an example method that may be employed by clinician programmer 20 to select and execute an electrode combination search algorithm according to the invention. Clinician programmer 20, and more specifically processor 50 of clinician programmer 20, identifies a configuration of electrode set 42 (70), and selects an electrode combination search algorithm 56 based on the configuration (72). Multiple algorithms 56 may be available for selection in order to allow clinician programmer 20 to address differences between electrode configurations, e.g., different numbers of leads and electrodes per leads. However, each of algorithms 56 may employ the common search methodology that was discussed above, and is illustrated by FIGS. 5A and 5B discussed below.
Clinician programmer 20 may identify the configuration of electrode set 42 by, for example, receiving input from the clinician via user interface 52 indicating the configuration. In other embodiments, information identifying the configuration of electrode set 42 may be stored in memory 54 or a memory of IMD 14 at implant. In such embodiments, clinician programmer 20 may retrieve the information from memory 54 or from IMD 14 via telemetry circuit 62.
Clinician programmer 20 then, as will be described in greater detail below, executes the selected search algorithm to select individual electrodes 40 and electrode combinations to test (74). When a combination is tested, clinician programmer 20 may, as will also be described in greater detail below, store information 58 relating to that combination in memory 54. The information may include amplitude information, and/or rating information provided by one or both of the clinician and patient 12.
Clinician programmer 20 may present a list of tested combinations to the clinician via display 22 (78). The list may include the information relating to each combination, and in some embodiments, may be ordered according to information. The list may facilitate identification of one or more desirable electrode combinations by the clinician. The clinician may create neurostimulation therapy programs 60 that include identified electrode combinations (80), and clinician programmer 20 may store information identifying the electrode combinations selected by the clinician in memory 54, and use the selected combinations to generate programs 60. In some embodiments, clinician programmer 20 may automatically select electrode combinations for inclusion in programs 60 based on the information.
FIG. 5A and 5B are flow diagrams illustrating an example electrode combination search algorithm that may be executed by clinician programmer 20. As shown in FIG. 5A, clinician programmer 20 identifies an initial position within electrode set 42 (90), and controls IMD 14 to test an electrode 40 located at the initial position as the first cathode (92). As discussed above, the initial position may be a central position within electrode set 42, and programmer 20 may identify a central position within set 42 based on the configuration of set 42. For example, programmer 20 may initially control IMD 14 to test electrode 40E (FIG. 2) as the first cathode. Alternatively, the clinician may identify the initial position or the specific electrode 40 that the clinician believes should be tested first, and clinician programmer 20 may control IMD 14 to test the electrode 40 corresponding to input provided by the clinician.
Clinician programmer 20 then determines whether an additional electrode 40 should be tested as the first cathode (94). Clinician programmer 20 may prompt the clinician to indicate whether an additional electrode 40 should be tested. If the clinician is satisfied with the first electrode 40 tested, clinician programmer 20 identifies the first electrode as the first cathode for subsequently tested combinations (98). However, if the clinician indicates that additional electrodes 40 should be tested, clinician programmer 20 may control IMD 14 to test additional electrodes 40 of electrode set 42 in an order based on decreasing proximity to the initial position until the clinician indicates that no more electrodes 40 should be tested or all electrodes 40 of electrode set 42 have been tested (96). At that point, programmer 20 may identify the first cathode (98) either as the last electrode 40 tested, or based on input from the clinician identifying which of the tested electrodes 40 should be identified as the first cathode.
When clinician programmer 20 controls IMD 14 to test one of electrodes 40 as the first cathode, another one of electrodes 40 adjacent to the tested electrode, or the can of IMD 14, acts as a first anode to form a cathode/anode pair. When one of the tested electrodes 40 is identified as the first cathode (96), clinician programmer 20 may determine based on input received from the clinician whether other electrodes 40 of electrode set 42 are to be tested as the first anode (100). If the clinician indicates that no additional electrodes are to be tested as the first anode, programmer may identify the already tested electrode 40 adjacent to the first cathode as the first anode (104).
However, if the clinician indicates that additional electrodes 40 should be tested as the first anode, clinician programmer 20 may control IMD 14 to test additional electrodes 40 of electrode set 42 in an order based on decreasing proximity to the first cathode until the clinician indicates that no more electrodes 40 should be tested or all electrodes 40 of electrode set 42 have been tested (102). At that point, clinician programmer 20 may identify the first anode (104) either as the last electrode 40 tested, or based on input from the clinician identifying which of the tested electrodes 40 should be identified as the first anode. Each first cathode/first anode pair tested forms an electrode combination.
FIG. 5B illustrates portions of the example algorithm that enable programmer 20 and the clinician to try adding anodes and/or cathodes to the existing first cathode/first anode pair. In response to input from the clinician indicating that an additional anode or cathode should be added to an existing combination, programmer 20 selects electrodes to test as the additional anode or cathode. Where the existing combination is the first cathode/first anode pair, the resulting combinations tested may include guarded cathode or guarded anode combinations known in the art.
If clinician programmer 20 receives an indication to try an additional anode (106), programmer 20 controls IMD 14 to test undesignated electrodes 40 of electrode set 42 in an order based on decreasing proximity to the first cathode (108) until programmer 20 receives an indication to stop testing electrodes 40 or until all electrodes 40 of electrode set 42 have been tested (110). If clinician programmer 20 receives an indication to try an additional cathode (112), programmer 20 controls IMD 14 to test undesignated electrodes 40 of electrode set 42 in an order based on decreasing proximity to the first cathode (114) until programmer 20 receives an indication to stop testing electrodes 40 or until all electrodes 40 of electrode set 42 have been tested (116). After testing combinations that include the identified first cathode/first anode pair, and one or more additional anodes and/or one or more additional cathodes, clinician programmer 20 may select a different first anode or first cathode based on input received from the clinician. When the clinician is satisfied that desirable electrode combinations have been identified, or when all electrode combinations have been tested, clinician programmer 20 ends the electrode search algorithm (118), and may display a list of tested combinations as described above.
If the clinician stops the search before all possible combinations of electrodes 40 have been tested, clinician programmer 20 may create a bracket of untested combinations that the clinician may elect to include in neurostimulation therapy programs. The bracket may consist of any number of electrode combinations, and may comprise the next n combinations that would have been tested according to the electrode combination search algorithm. By providing the clinician with a bracket, clinician programmer 20 may allow clinician to spend less time searching for desirable electrode combinations. Specifically, the programs created using the bracket combinations may enable desirable neurostimulation therapy similar to that provided a program created with the most recently tested combination, and may be provided to patient 12 so that patient 12 can experiment with the bracket programs outside of the clinic.
FIGS. 6A-6K are diagrams illustrating example matrices 120-220 that illustrate positions within exemplary electrode sets. FIGS. 6A-B, D-E and H-J illustrate two-by-eight matrices 120, 130, 150, 160, 190, 200 and 210 that identify positions within a two-by-eight side-by-side electrode set, such as electrode set 42. FIGS. 6C, F-G and K illustrate one-by-eight matrices 140, 170, 180 and 220 that identify positions within a one-by-eight or two-by-four in-line electrode set. More particularly, FIGS. 6A-6K illustrate orders in which clinician programmer 20 may select electrodes within such electrode sets to test according to electrode combination search algorithms consistent with the invention, each position within a matrix indicating an electrode within an electrode set.
Matrices 120, 130 and 140 of FIGS. 6A-C illustrate orders in which clinician programmer 20 may select electrodes to test as the first cathode. The “−” symbol in each of matrices 120, 130 and 140 indicates the initial position, i.e., the first electrode tested as the first cathode. Additional electrodes may be tested as a first cathode in the numeric orders illustrated, which illustrate examples of testing orders that are based on decreasing proximity to the initial position.
Matrices 150, 160, 170 and 180 of FIGS. 6D-G illustrate orders in which clinician programmer 20 may select electrodes to test with an identified first cathode as the first anode. The “−” symbol in each of matrices 150, 160, 170 and 180 indicates the identified position of the first cathode. The “+” symbol in each of matrices 150, 160, 170 and 180 indicates the position of an electrode already tested with the first cathode as the first anode during the process of identifying the first cathode. Other electrodes of an electrode set corresponding to one of matrices 150, 160, 170 and 180 may be tested as a first anode in the numeric orders illustrated, which illustrate examples of testing orders that are based on decreasing proximity to the identified first cathode.
Matrices 190, 200, 210 and 220 of FIGS. 6H-K illustrate orders in which clinician programmer 20 may select electrodes to test with an identified first cathode/first anode pair as an additional anode. The “−” symbol in each of matrices 190, 200, 210 and 220 indicates the identified position of the first cathode. The “+” symbol in each of matrices 190, 200, 210 and 220 indicates the identified position of the first anode. Clinician programmer 20 may test other undesignated electrodes of an electrode set corresponding to one of matrices 190, 200, 210 and 220 as an additional anode in the numeric orders illustrated, which illustrate examples of testing orders that are based on decreasing proximity to the identified first cathode.
As illustrated by matrices 190, 210 and 220, clinician programmer 20 may test only a subset of the undesignated electrodes of an electrode set. Specifically, clinician programmer 20 may avoid testing electrodes as an additional anode that would provide substantially the same current flow as the first cathode/first anode pair due to the orientation of the additional anode and the first cathode/first anode pair. By testing only a subset of the undesignated electrodes and avoiding redundant combinations, clinician programmer 20 may further shorten the time required of the clinician to identify desirable electrode combinations.
The illustrated matrices are merely exemplary. Again, clinician programmer 20 may test electrodes within any type of electrode configuration. Further, configurations that include multiple additional anodes, or one or more additional cathodes may be tested. Whenever a cathode or anode is added, testing may be limited to a subset of undesignated electrodes in order to avoid redundant combinations.
FIG. 7 is a flow diagram illustrating an example method that may be employed by clinician programmer 20 to test an electrode combination according to the invention. Specifically, FIG. 7 illustrates a method that may be employed by clinician programmer 20 each time a new electrode is tested as a first or additional cathode, or first or additional anode. In other words, FIG. 7 illustrates a method that may be employed by clinician programmer 20 each time clinician programmer 20 identifies a new electrode combination to test (230).
Clinician programmer 20 controls IMD 14 to test the combination by controlling IMD 14 to deliver neurostimulation therapy via the combination. The clinician may select desired starting points for pulse amplitude, rate and width, and clinician programmer 20 may ramp the amplitude from the starting point at a first rate of amplitude increase (232). Clinician programmer 20 may increase the amplitude in, for example, a linear or step-wise fashion. In some embodiments, the clinician or patient 12 may control the rate of amplitude increase. The clinician or patient 12 stops the ramping of the amplitude when the stimulation causes discomfort, or other undesirable side effects (234).
Clinician programmer 20 may reduce the amplitude at the time the ramp is stopped by some amount, e.g., a percentage, and ramps the amplitude again in order to allow the clinician and/or patient 12 to identify the amplitude that provides the best neurostimulation therapy (236, 238). This second time, clinician programmer 20 may ramp the amplitude at a slower rate of amplitude increase in order to facilitate identification of the point where best neurostimulation is achieved. Again, in some embodiments, the clinician or patient 12 may control the amplitude.
Clinician programmer 20 stores the amplitude at the time when the best neurostimulation therapy is indicated by the clinician and/or patient 12, and rating information for the combination (240, 242). The clinician and/or patient 12 may provide rating information, e.g., a numerical value for one or more metrics for rating the combination, which relates to the efficacy enabled by the combination or the side effects resulting from use of the combination, or both.
The clinician may use rating information and/or the amplitude values stored for each tested combination to identify desirable combinations. The combinations and their associated information and values may be presented in a list that may be ordered according to the information, the values, or a combination of the two. The amplitude value may, for example, be used to distinguish between tested combinations with similar ratings based on the power that must be consumed in order for each combination to enable desirable neurostimulation therapy.
FIG. 8 is a flow diagram illustrating an example method that may be employed by clinician programmer 20 to replicate a selected neurostimulation therapy program. After identifying a plurality of desirable electrode combinations in the manner described above, the clinician or patient 12 may use clinician programmer 20 to test variety of values of other neurostimulation therapy program parameters, such as pulse amplitude, pulse rate, pulse width and duty cycle, with the identified electrode combinations, i.e., to test a variety of neurostimulation therapy programs 60. Clinician programmer 20 may collect rating information for each of the tested neurostimulation therapy programs, e.g., information indicating efficacy, side effects, or power consumption of each of the programs. Clinician programmer 20 identifies a plurality of desirable neurostimulation therapy programs 60 from among those tested during the programming session for use in controlling delivery of neurostimulation therapy to patient 12 by IMD 14, e.g., receives selections from among programs 60 made by the clinician via user interface 52 (250).
Clinician programmer 20 selects one of the neurostimulation therapy programs identified during the programming session, e.g., receives a selection of one of the programs made by the clinician, and receives a replication command from the clinician (252, 254). In response to the replication command, clinician programmer 20 generates one or more copies of the selected neurostimulation therapy program (256). Clinician programmer 20 provides the selected neurostimulation therapy program 60 and the one or more copies to at least one of IMD 14 and patient programmer 24, where they may be individually selected and used to control delivery of therapy by IMD 14 (258).
By replicating a neurostimulation therapy program that has been identified as desirable, clinician programmer 20 may allow a clinician to quickly generate a plurality of similarly desirable programs for selection and use by patient 12. In some embodiments, as part of generation of a copy (256), clinician programmer 20 may change one or more of the parameters of the selected program. For example, one or more of pulse amplitude, pulse width, pulse rate, or duty cycle may be changed to provide a plurality of similar programs with various intensities and battery consumption rates, e.g., clinician programmer may provide a “high intensity” and “low intensity” version of a selected program.
By providing a plurality of programs that are replicated with parameters that are changed in this manner, clinician programmer 20 may allow patient 12 to select a program that addresses a current symptom level, e.g., pain level which may vary based on patient posture, activity or time of day, with a comparatively lower rate of battery consumption. In some embodiments, clinician programmer 20 may associate the selected program and the copies with respective postures, activities, times of day, symptom intensity states, or program side effect states, e.g., may label a selected program and a copy as “sitting” and “standing,” “active” and “inactive,” “daytime” and “nighttime,” or “high” and “low,” respectively. In other embodiments, patient 12 may be unaware of the differences between the intensities of the program and the copies, and either IMD 14 or patient programmer 26 may collect information regarding the use of the program and the copies to determine whether patient 12 will accept a program with a lower intensity and battery consumption rate. In some embodiments, clinician programmer 20 may provide one or more copies that are identical to the selected program, and patient 12 may adjust one or more parameters of the copies to create similarly desirable programs with different intensities and battery consumption rates to, for example, address different symptom levels associated with different postures or activities.
Clinician programmer 20 may change one or more parameters of a program when creating a copy of the program by a user-selected amount or a predetermined amount. For example, in situations in which desirable programs are identified when patient 12 is in a sitting posture, clinician programmer 20 may generate a copy of at least one of the programs to be a “standing” version of the selected program. Clinician programmer 20 may change an intensity related parameter of the selected program, e.g., amplitude, by a predetermined amount that is substantially equal to the difference between an average pulse amplitude used by patients when sitting and an average pulse amplitude used by patients when standing. The predetermined amount may be determined experimentally, and may be stored in memory 54 such that it is available to processor 50.
As another example of a technique for generating one or more copies of a program by changing one or more parameters by a predetermined amount, clinician programmer 20 may generate a “high intensity” and/or a “low intensity” version of a program based on stimulation thresholds identified during the programming session. A pain threshold and a perception threshold are examples of stimulation thresholds that may be identified during a programming session. Clinician programmer 20 may identify the values of one or more intensity related program parameters, such as pulse amplitude and pulse width, that result in identification of these thresholds by patient 12, and may change parameter values when generating high intensity or low intensity copies of a program based on the parameter values associated with the thresholds. For example, clinician programmer 20 may generate a high intensity copy of a selected program such that one or more program parameter values of the copy are substantially equal to the values associated with a pain threshold, and may generate a low intensity copy of a selected program such that one or more program parameter values of the copy are substantially equal to the values associated with the perception threshold.
FIG. 9 is a flow diagram illustrating an example method that may be employed by clinician programmer 20 to automatically generate program groups based on program categories associated with neurostimulation therapy programs. Clinician programmer 20 identifies a plurality of desirable neurostimulation therapy programs 60 from among those tested during a programming session, e.g., receives selections from among programs 60 made by the clinician via user interface 52 (260). Clinician programmer 20 then associates each of the plurality of identified neurostimulation therapy programs with one or more of a plurality of program categories (262), and automatically generates a plurality of program groups, e.g., automatically assigns programs to groups, based on their associated program categories (262, 264). Clinician programmer 20, as indicated above, may automatically generate the program groups in response to receiving a program group generation command from the clinician via user interface 52.
As indicated above, each of the program categories is related to a characteristic of neurostimulation therapy programs. Clinician programmer 20 may generate program groups to include programs associated with different categories, e.g., programs associated with different paresthesia or electrode locations, or may generate program groups to include programs associated with same category, e.g., programs associated with same intensity or same posture. In exemplary embodiments, clinician programmer 20 combinatorially generates program groups from a set neurostimulation therapy programs identified during a programming session. In other words, clinician programmer 20 may automatically generate a plurality of program groups by generating multiple combinations of neurostimulation therapy programs that comply with one or more criteria related to program categories. In some embodiments, clinician programmer 20 may order the programs within each category according to rating information, e.g., collected during a neurostimulation programming session, and may maintain a preference for use of more “highly” rated programs when combining programs to create groups, e.g., may create program groups based on both the program categories and the rating information. For example, clinician programmer 20 may exclude “poorly” rated programs from program groups, or may assign higher rated programs to groups more frequently than lower rated programs.
Various embodiments of the invention have been described. However, one skilled in the art will appreciate that various additions and modifications can be made to these embodiments without departing from the scope of the invention. For example, although programmer 20 has been described herein as a hand-held computing device, clinician programmer 20 may take the form of any type of computing device, such as a laptop or desktop computer, may access resources, such as memory 54, via a computer network, such as a LAN, WAN, or the World Wide Web. Further, clinician programmer 20 may include a plurality of computing devices, which may communicate to provide the functionality ascribed to clinician programmer 20 herein via a computer network.
Although described herein as associated with and interacting with a clinician, clinician programmer 20 may additionally or alternatively be associated with patient 12, i.e., act as a patient programmer. In some embodiments, patient 12 may simply interact with programmer 20 in place of the clinician for some or all of the electrode combination and neurostimulation therapy program identification process. In other embodiments, patient 12 may perform parts of the combination identification process without being supervised by the clinician, e.g., away from the clinic, using patient programmer 26.
Additionally, neurostimulation programs selected for replication and/or combination into program groups need not be programs identified during a neurostimulation programming session. For example, programs retrieved from a trial neurostimulator or patient programmer 26, such as programs that are the result of patient adjustment parameters over a trialing period, may be replicated and/or combined into program groups. Similarly, programs may be retrieved from IMD 14 or patient programmer 26 during a follow up visit, and selected for replication and/or program group generation based on usage or rating information stored by IMD 14 or patient programmer 26. Further, the clinician may store neurostimulation therapy programs that have been identified as generally efficacious, e.g., during treatment of other patients, in memory 56 or another memory accessible by clinician programmer 20, and may select such programs for replication and/or combination into program groups. These and other embodiments are within the scope of the following claims.

Claims (31)

1. A method comprising:
selecting a neurostimulation therapy program that includes a set of neurostimulation therapy parameters;
receiving a replication command from a user;
automatically generating a copy of the selected neurostimulation therapy program in response to the replication command, wherein automatically generating a copy comprises automatically generating the copy with a value of at least one of the neurostimulation therapy parameters modified relative to a value of the neurostimulation therapy parameter for the selected program in response to the command; and
providing the selected neurostimulation therapy program and the copy to at least one of a programming device or a medical device, wherein a selected one or more of the neurostimulation therapy program and the copy controls delivery of neurostimulation therapy to a patient by the medical device.
2. The method of claim 1, wherein the modified neurostimulation therapy parameter value comprises an amplitude of the selected neurostimulation therapy program.
3. The method of claim 1, wherein the modified neurostimulation therapy parameter value comprises a duty cycle of the selected neurostimulation therapy program.
4. The method of claim 1, wherein automatically generating the copy with a value of at least one of the neurostimulation therapy parameters modified relative to a value of the neurostimulation therapy parameter for the selected program comprises changing the neurostimulation therapy parameter value by an amount selected by the user.
5. The method of claim 1, wherein automatically generating the copy with a value of at least one of the neurostimulation therapy parameters modified relative to a value of the neurostimulation therapy parameter for the selected program comprises changing the neurostimulation therapy parameter value by a predetermined amount.
6. The method of claim 1, wherein automatically generating a copy comprises at least one of automatically generating a copy that provides a higher neurostimulation intensity relative to the selected neurostimulation therapy program or automatically generating a copy that provides a lower neurostimulation intensity relative to the selected neurostimulation therapy program.
7. The method of claim 6, wherein automatically generating a copy that provides a higher neurostimulation intensity comprises generating the copy with an amplitude approximately equal to a previously determined pain threshold of the patient, and automatically generating a copy that provides a lower neurostimulation intensity comprises generating the copy with the amplitude approximately equal to a previously determined perception threshold of the patient.
8. The method of claim 1,
wherein automatically generating a copy of the selected neurostimulation therapy program comprises automatically generating a plurality of copies of the selected neurostimulation therapy program, each of the copies having a respective value of the neurostimulation therapy parameter that is modified relative to the value of the neurostimulation therapy parameter for the selected program, in response to the replication command, and
wherein providing the selected neurostimulation therapy program and the copy to at least one of a programming device or a medical device comprises providing the selected neurostimulation therapy program and the plurality of copies to at least one of the programming device or the medical device.
9. The method of claim 1, wherein providing the selected neurostimulation therapy program and the copy to at least one of a programming device or a medical device comprises:
including the selected neurostimulation therapy program in a first program group that includes one or more neurostimulation therapy programs;
including the copy in a second program group that includes one or more neurostimulation therapy programs; and
providing the first and second program groups to at least one of the programming device or the medical device, wherein a selected one of the first and second groups controls delivery of neurostimulation therapy to the patient by the medical device.
10. The method of claim 1, further comprising associating the selected neurostimulation therapy program and the copy with at least one of respective patient postures or respective patient activities.
11. The method of claim 1, further comprising associating the selected neurostimulation therapy program and the copy with respective times of day.
12. The method of claim 1, further comprising associating the selected neurostimulation therapy program and the copy with at least one of respective symptom states or respective side effect states.
13. The method of claim 1, wherein selecting a neurostimulation therapy program comprises selecting one of a plurality of neurostimulation therapy programs identified during a programming session.
14. The method of claim 1, wherein selecting a neurostimulation therapy program comprises receiving a selection of the neurostimulation therapy program by the user.
15. A device comprising:
a user interface;
a communication circuit; and
a processor to select a neurostimulation therapy program that includes a set of neurostimulation therapy parameters, receive a replication command from a user via the user interface, automatically generate a copy of the selected neurostimulation therapy program in response to the replication command, and provide the selected neurostimulation therapy program and the copy to at least one of a programming device or a medical device via the communication circuit,
wherein a selected one or more of the neurostimulation therapy program and the copy controls delivery of neurostimulation therapy to a patient by the medical device, and
wherein the processor automatically generates the copy with a value of at least one of the neurostimulation therapy parameters modified relative to a value of the neurostimulation therapy parameter for the selected program in response to the replication command.
16. The device of claim 15, wherein the processor automatically generates the copy with an amplitude modified relative to an amplitude of the selected neurostimulation therapy program.
17. The device of claim 15, wherein the processor automatically generates the copy with a duty cycle modified relative to a duty cycle of the selected neurostimulation therapy program.
18. The device of claim 15, wherein the processor changes the parameter value by an amount selected by the user when generating the copy.
19. The device of claim 15, wherein the processor changes the parameter value by a predetermined amount when generating the copy.
20. The device of claim 15, wherein the processor automatically generates at least one of a copy that provides a higher neurostimulation intensity relative to the selected neurostimulation therapy program or a copy that provides a lower neurostimulation intensity relative to the selected neurostimulation therapy program.
21. The device of claim 20, wherein the copy that provides a higher neurostimulation intensity includes an amplitude approximately equal to a previously determined pain threshold of the patient, and the copy that provides a lower neurostimulation includes an amplitude approximately equal to a perception threshold of the patient.
22. The device of claim 15, wherein the processor automatically generates a plurality of copies of the selected neurostimulation therapy program, each of the copies having a respective value of the neurostimulation therapy parameter that is modified relative to the value of the neurostimulation therapy parameter for the selected program, in response to the replication command, and provides the selected neurostimulation therapy program and the plurality of copies to at least one of the programming device or the medical device via the communication circuit.
23. The device of claim 15,
wherein the processor includes the selected neurostimulation therapy program in a first program group that includes one or more neurostimulation therapy programs, includes the copy in a second program group that includes one or more neurostimulation therapy programs, and provides the first and second program groups to at least one of the programming device or the medical device, and
wherein a selected one of the first and second groups controls delivery of neurostimulation therapy to the patient by the medical device.
24. The device of claim 15, wherein the processor associates the selected neurostimulation therapy program and the copy with at least one of respective patient postures or respective patient activities.
25. The device of claim 15, wherein the processor associates the selected neurostimulation therapy program and the copy with respective times of day.
26. The device of claim 15, wherein the processor associates the selected neurostimulation therapy program and the copy with at least one of respective symptom states or respective side effect states.
27. The device of claim 15, wherein the selected neurostimulation therapy program is one of a plurality of neurostimulation therapy programs identified during a programming session.
28. The device of claim 15, wherein the processor receives a selection of the neurostimulation therapy program made by the user via the user interface.
29. A computer-readable medium comprising instructions that cause a programmable processor to:
select a neurostimulation therapy program that includes a set of neurostimulation therapy parameters;
receive a replication command from a user;
automatically generate a copy of the selected neurostimulation therapy program in response to the replication command; and
provide the selected neurostimulation therapy program and the copy to at least one of a programming device or a medical device,
wherein a selected one or more of the neurostimulation therapy program and the copy controls delivery of neurostimulation therapy to a patient by the medical device, and
wherein the instructions that cause a programmable processor to automatically generate a copy comprises instructions that cause the programmable processor to automatically generate the copy with a value of at least one of the neurostimulation therapy parameters modified relative to a value of the neurostimulation therapy parameter for the selected program in response to the replication command.
30. The computer-readable medium of claim 29,
wherein the instructions that cause the programmable processor to automatically generate a copy of the selected neurostimulation therapy program comprise instructions that cause the programmable processor to automatically generate a plurality of copies of the selected neurostimulation therapy program in response to the replication command, each of the copies having a respective value of the neurostimulation therapy parameter that is modified relative to the value of neurostimulation parameter for the selected program, and
wherein the instructions that cause a programmable processor to provide the selected neurostimulation therapy program and the copy to at least one of a programming device or a medical device comprise instructions that cause the programmable processor to provide the selected neurostimulation therapy program and the plurality of copies to at least one of the programming device or the medical device.
31. The computer-readable medium of claim 29, wherein the instructions that cause the programmable processor to provide the selected neurostimulation therapy program and the copy to at least one of a programming device or a medical device comprise instructions that cause a programmable processor to:
include the selected neurostimulation therapy program in a first program group that includes one or more neurostimulation therapy programs;
include the copy in a second program group that includes one or more neurostimulation therapy programs; and
provide the first and second program groups to at least one of the programming device or the medical device, wherein a selected one of the first and second groups controls delivery of neurostimulation therapy to the patient by the medical device.
US10/831,971 2003-04-25 2004-04-26 Generation of therapy programs and program groups Active 2026-11-16 US7826901B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/831,971 US7826901B2 (en) 2003-04-25 2004-04-26 Generation of therapy programs and program groups
US11/698,655 US8068915B2 (en) 2003-04-25 2007-01-26 Generation of therapy programs and program groups

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/424,194 US7463928B2 (en) 2003-04-25 2003-04-25 Identifying combinations of electrodes for neurostimulation therapy
US10/831,971 US7826901B2 (en) 2003-04-25 2004-04-26 Generation of therapy programs and program groups

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/424,194 Continuation-In-Part US7463928B2 (en) 2003-04-25 2003-04-25 Identifying combinations of electrodes for neurostimulation therapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/698,655 Division US8068915B2 (en) 2003-04-25 2007-01-26 Generation of therapy programs and program groups

Publications (2)

Publication Number Publication Date
US20040267330A1 US20040267330A1 (en) 2004-12-30
US7826901B2 true US7826901B2 (en) 2010-11-02

Family

ID=33299298

Family Applications (5)

Application Number Title Priority Date Filing Date
US10/424,194 Active 2025-12-09 US7463928B2 (en) 2003-04-25 2003-04-25 Identifying combinations of electrodes for neurostimulation therapy
US10/831,971 Active 2026-11-16 US7826901B2 (en) 2003-04-25 2004-04-26 Generation of therapy programs and program groups
US11/404,069 Active 2026-03-28 US9186517B2 (en) 2003-04-25 2006-04-13 Identifying combinations of electrodes for neurostimulation therapy
US11/698,655 Expired - Fee Related US8068915B2 (en) 2003-04-25 2007-01-26 Generation of therapy programs and program groups
US13/310,136 Expired - Lifetime US8649872B2 (en) 2003-04-25 2011-12-02 Identifying combinations of electrodes for neurostimulation therapy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/424,194 Active 2025-12-09 US7463928B2 (en) 2003-04-25 2003-04-25 Identifying combinations of electrodes for neurostimulation therapy

Family Applications After (3)

Application Number Title Priority Date Filing Date
US11/404,069 Active 2026-03-28 US9186517B2 (en) 2003-04-25 2006-04-13 Identifying combinations of electrodes for neurostimulation therapy
US11/698,655 Expired - Fee Related US8068915B2 (en) 2003-04-25 2007-01-26 Generation of therapy programs and program groups
US13/310,136 Expired - Lifetime US8649872B2 (en) 2003-04-25 2011-12-02 Identifying combinations of electrodes for neurostimulation therapy

Country Status (5)

Country Link
US (5) US7463928B2 (en)
EP (2) EP1617897B1 (en)
AT (2) ATE510583T1 (en)
DE (1) DE602004008905T2 (en)
WO (2) WO2004096349A1 (en)

Cited By (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120203304A1 (en) * 2009-04-22 2012-08-09 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8509906B2 (en) 2009-01-29 2013-08-13 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US8630715B2 (en) 2006-04-12 2014-01-14 Medtronic, Inc. Rule-based stimulation program search
US8649874B2 (en) 2010-11-30 2014-02-11 Nevro Corporation Extended pain relief via high frequency spinal cord modulation, and associated systems and methods
US20140067006A1 (en) * 2012-08-31 2014-03-06 Greatbatch Ltd. Method and System of Quick Neurostimulation Electrode Configuration and Positioning
US20140067016A1 (en) * 2012-08-31 2014-03-06 Greatbatch Ltd. Method and System of Bracketing Stimulation Parameters on Clinician Programmers
US8676331B2 (en) 2012-04-02 2014-03-18 Nevro Corporation Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection
US8768472B2 (en) 2007-11-05 2014-07-01 Nevro Corporation Multi-frequency neural treatments and associated systems and methods
US8798754B2 (en) 2005-09-26 2014-08-05 Venturi Group, Llc Neural blocking therapy
US9044614B2 (en) 2013-03-15 2015-06-02 Alfred E. Mann Foundation For Scientific Research High voltage monitoring successive approximation analog to digital converter
US9155901B2 (en) 2013-07-29 2015-10-13 Alfred E. Mann Foundation For Scientific Research Implant charging field control through radio link
US9166441B2 (en) 2013-07-29 2015-10-20 Alfred E. Mann Foundation For Scientific Research Microprocessor controlled class E driver
US9205273B2 (en) 2013-07-29 2015-12-08 Alfred E. Mann Foundation For Scientific Research High efficiency magnetic link for implantable devices
US9221119B2 (en) 2013-05-03 2015-12-29 Alfred E. Mann Foundation For Scientific Research High reliability wire welding for implantable devices
US9278215B2 (en) 2011-09-08 2016-03-08 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9308378B2 (en) 2013-05-03 2016-04-12 Alfred E. Mann Foundation For Scientific Research Implant recharger handshaking system and method
US9409019B2 (en) 2009-07-28 2016-08-09 Nevro Corporation Linked area parameter adjustment for spinal cord stimulation and associated systems and methods
US9409020B2 (en) 2014-05-20 2016-08-09 Nevro Corporation Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods
US9427574B2 (en) 2014-08-15 2016-08-30 Axonics Modulation Technologies, Inc. Implantable lead affixation structure for nerve stimulation to alleviate bladder dysfunction and other indication
US9433779B2 (en) 2013-05-03 2016-09-06 Alfred E. Mann Foundation For Scientific Research Multi-branch stimulation electrode for subcutaneous field stimulation
US9446241B2 (en) 2013-03-15 2016-09-20 Alfred E. Mann Foundation For Scientific Research Current sensing multiple output current stimulators
US9517338B1 (en) 2016-01-19 2016-12-13 Axonics Modulation Technologies, Inc. Multichannel clip device and methods of use
US9533155B2 (en) 2014-08-15 2017-01-03 Axonics Modulation Technologies, Inc. Methods for determining neurostimulation electrode configurations based on neural localization
US9555246B2 (en) 2014-08-15 2017-01-31 Axonics Modulation Technologies, Inc. Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US9700731B2 (en) 2014-08-15 2017-07-11 Axonics Modulation Technologies, Inc. Antenna and methods of use for an implantable nerve stimulator
US9728981B2 (en) 2012-08-31 2017-08-08 Alfred E. Mann Foundation For Scientific Research Feedback controlled coil driver for inductive power transfer
US9737717B2 (en) 2014-09-15 2017-08-22 Boston Scientific Neuromodulation Corporation Graphical user interface for programming neurostimulation pulse patterns
US9802051B2 (en) 2014-08-15 2017-10-31 Axonics Modulation Technologies, Inc. External pulse generator device and associated methods for trial nerve stimulation
US9802052B2 (en) 2014-11-04 2017-10-31 Boston Scientific Neuromodulation Corporation Method and apparatus for programming complex neurostimulation patterns
US9833614B1 (en) 2012-06-22 2017-12-05 Nevro Corp. Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US9895539B1 (en) 2013-06-10 2018-02-20 Nevro Corp. Methods and systems for disease treatment using electrical stimulation
US9895546B2 (en) 2015-01-09 2018-02-20 Axonics Modulation Technologies, Inc. Patient remote and associated methods of use with a nerve stimulation system
US9925381B2 (en) 2015-07-10 2018-03-27 Axonics Modulation Technologies, Inc. Implantable nerve stimulator having internal electronics without ASIC and methods of use
US10092762B2 (en) 2014-08-15 2018-10-09 Axonics Modulation Technologies, Inc. Integrated electromyographic clinician programmer for use with an implantable neurostimulator
US10149978B1 (en) 2013-11-07 2018-12-11 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
US10195423B2 (en) 2016-01-19 2019-02-05 Axonics Modulation Technologies, Inc. Multichannel clip device and methods of use
US10300277B1 (en) 2015-12-14 2019-05-28 Nevro Corp. Variable amplitude signals for neurological therapy, and associated systems and methods
US10335601B2 (en) 2015-07-30 2019-07-02 Boston Scientific Neuromodulation Corporation User interface for custom patterned electrical stimulation
US10376704B2 (en) 2016-02-12 2019-08-13 Axonics Modulation Technologies, Inc. External pulse generator device and associated methods for trial nerve stimulation
US10456586B2 (en) 2015-10-15 2019-10-29 Boston Scientific Neuromodulation Corporation User interface for neurostimulation waveform composition
US10493275B2 (en) 2009-04-22 2019-12-03 Nevro Corp. Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods
US10561835B2 (en) 2006-10-31 2020-02-18 Medtronic, Inc. Implantable medical lead with threaded fixation
US10603500B2 (en) 2016-01-29 2020-03-31 Axonics Modulation Technologies, Inc. Methods and systems for frequency adjustment to optimize charging of implantable neurostimulator
US10682521B2 (en) 2014-08-15 2020-06-16 Axonics Modulation Technologies, Inc. Attachment devices and associated methods of use with a nerve stimulation charging device
US10799701B2 (en) 2016-03-30 2020-10-13 Nevro Corp. Systems and methods for identifying and treating patients with high-frequency electrical signals
US11058875B1 (en) 2018-09-19 2021-07-13 Nevro Corp. Motor function in spinal cord injury patients via electrical stimulation, and associated systems and methods
US11110283B2 (en) 2018-02-22 2021-09-07 Axonics, Inc. Neurostimulation leads for trial nerve stimulation and methods of use
US11318310B1 (en) 2015-10-26 2022-05-03 Nevro Corp. Neuromodulation for altering autonomic functions, and associated systems and methods
US11439829B2 (en) 2019-05-24 2022-09-13 Axonics, Inc. Clinician programmer methods and systems for maintaining target operating temperatures
US11446504B1 (en) 2016-05-27 2022-09-20 Nevro Corp. High frequency electromagnetic stimulation for modulating cells, including spontaneously active and quiescent cells, and associated systems and methods
US11484723B2 (en) 2015-01-09 2022-11-01 Axonics, Inc. Attachment devices and associated methods of use with a nerve stimulation charging device
US11590352B2 (en) 2019-01-29 2023-02-28 Nevro Corp. Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods
US11596798B2 (en) 2016-01-25 2023-03-07 Nevro Corp Treatment of congestive heart failure with electrical stimulation, and associated systems and methods
US11602634B2 (en) 2019-01-17 2023-03-14 Nevro Corp. Sensory threshold adaptation for neurological therapy screening and/or electrode selection, and associated systems and methods
US11633604B2 (en) 2018-01-30 2023-04-25 Nevro Corp. Efficient use of an implantable pulse generator battery, and associated systems and methods
US11642537B2 (en) 2019-03-11 2023-05-09 Axonics, Inc. Charging device with off-center coil
US11848090B2 (en) 2019-05-24 2023-12-19 Axonics, Inc. Trainer for a neurostimulator programmer and associated methods of use with a neurostimulation system

Families Citing this family (181)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060217782A1 (en) * 1998-10-26 2006-09-28 Boveja Birinder R Method and system for cortical stimulation to provide adjunct (ADD-ON) therapy for stroke, tinnitus and other medical disorders using implantable and external components
US7062330B1 (en) * 1998-10-26 2006-06-13 Boveja Birinder R Electrical stimulation adjunct (Add-ON) therapy for urinary incontinence and urological disorders using implanted lead stimulus-receiver and an external pulse generator
US7881805B2 (en) * 2002-02-04 2011-02-01 Boston Scientific Neuromodulation Corporation Method for optimizing search for spinal cord stimulation parameter settings
US8233991B2 (en) 2002-02-04 2012-07-31 Boston Scientific Neuromodulation Corporation Method for programming implantable device
US7146223B1 (en) 2002-02-04 2006-12-05 Advanced Bionics Corporation Method for optimizing search for spinal cord stimulation parameter settings
US7991482B2 (en) * 2002-02-04 2011-08-02 Boston Scientific Neuromodulation Corporation Method for optimizing search for spinal cord stimulation parameter setting
US7463928B2 (en) 2003-04-25 2008-12-09 Medtronic, Inc. Identifying combinations of electrodes for neurostimulation therapy
US20050004622A1 (en) * 2003-07-03 2005-01-06 Advanced Neuromodulation Systems System and method for implantable pulse generator with multiple treatment protocols
JP2007501067A (en) 2003-08-01 2007-01-25 ノーススター ニューロサイエンス インコーポレイテッド Apparatus and method for applying neural stimulation to patient
US7647114B2 (en) * 2003-12-24 2010-01-12 Cardiac Pacemakers, Inc. Baroreflex modulation based on monitored cardiovascular parameter
US8024050B2 (en) * 2003-12-24 2011-09-20 Cardiac Pacemakers, Inc. Lead for stimulating the baroreceptors in the pulmonary artery
US20050149132A1 (en) 2003-12-24 2005-07-07 Imad Libbus Automatic baroreflex modulation based on cardiac activity
US9020595B2 (en) 2003-12-24 2015-04-28 Cardiac Pacemakers, Inc. Baroreflex activation therapy with conditional shut off
US8180601B2 (en) 2006-03-09 2012-05-15 The Cleveland Clinic Foundation Systems and methods for determining volume of activation for deep brain stimulation
US8209027B2 (en) 2004-07-07 2012-06-26 The Cleveland Clinic Foundation System and method to design structure for delivering electrical energy to tissue
US7346382B2 (en) 2004-07-07 2008-03-18 The Cleveland Clinic Foundation Brain stimulation models, systems, devices, and methods
US8788044B2 (en) 2005-01-21 2014-07-22 Michael Sasha John Systems and methods for tissue stimulation in medical treatment
US7555345B2 (en) 2005-03-11 2009-06-30 Medtronic, Inc. Implantable neurostimulator device
US7231256B2 (en) * 2005-03-11 2007-06-12 Medtronic, Inc. Neurostimulation site screening
EP2039391B1 (en) 2005-04-11 2013-09-04 Medtronic, Inc. Shifting between electrode combinations of an electrical stimulation device
WO2006110206A1 (en) * 2005-04-11 2006-10-19 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US7519431B2 (en) 2005-04-11 2009-04-14 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US7657317B2 (en) 2005-04-26 2010-02-02 Boston Scientific Neuromodulation Corporation Evaluating stimulation therapies and patient satisfaction
US7644714B2 (en) 2005-05-27 2010-01-12 Apnex Medical, Inc. Devices and methods for treating sleep disorders
US7616990B2 (en) 2005-10-24 2009-11-10 Cardiac Pacemakers, Inc. Implantable and rechargeable neural stimulator
WO2010065888A2 (en) 2008-12-04 2010-06-10 The Cleveland Clinic Foundation System and method to define target volume for stimulation in brain
US7801601B2 (en) * 2006-01-27 2010-09-21 Cyberonics, Inc. Controlling neuromodulation using stimulus modalities
US20070179558A1 (en) * 2006-01-30 2007-08-02 Gliner Bradford E Systems and methods for varying electromagnetic and adjunctive neural therapies
US8606360B2 (en) * 2006-03-09 2013-12-10 The Cleveland Clinic Foundation Systems and methods for determining volume of activation for spinal cord and peripheral nerve stimulation
US9067076B2 (en) * 2006-03-09 2015-06-30 Medtronic, Inc. Management of multiple stimulation program groups
EP1998848B1 (en) 2006-03-23 2014-09-17 Medtronic, Inc. Guided programming with feedback
US7774067B2 (en) * 2006-04-12 2010-08-10 Medtronic, Inc. Autogeneration of neurostimulation therapy program groups
US8306624B2 (en) 2006-04-28 2012-11-06 Medtronic, Inc. Patient-individualized efficacy rating
US8380300B2 (en) 2006-04-28 2013-02-19 Medtronic, Inc. Efficacy visualization
US7715920B2 (en) 2006-04-28 2010-05-11 Medtronic, Inc. Tree-based electrical stimulator programming
EP2043729B1 (en) * 2006-06-30 2013-01-02 Medtronic, Inc. Selecting electrode combinations for stimulation therapy
US8103341B2 (en) 2006-08-25 2012-01-24 Cardiac Pacemakers, Inc. System for abating neural stimulation side effects
US8620422B2 (en) * 2006-09-28 2013-12-31 Cvrx, Inc. Electrode array structures and methods of use for cardiovascular reflex control
EP2478931B1 (en) 2006-10-13 2015-12-30 Cyberonics, Inc. Obstructive sleep apnea treatment device
US9186511B2 (en) 2006-10-13 2015-11-17 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8855771B2 (en) 2011-01-28 2014-10-07 Cyberonics, Inc. Screening devices and methods for obstructive sleep apnea therapy
US9205262B2 (en) 2011-05-12 2015-12-08 Cyberonics, Inc. Devices and methods for sleep apnea treatment
US9913982B2 (en) 2011-01-28 2018-03-13 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US9744354B2 (en) 2008-12-31 2017-08-29 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8090446B2 (en) * 2007-04-19 2012-01-03 Advanced Neuromodulation Systems, Inc. Methods and systems for establishing neural stimulation parameters and providing neural stimulation
WO2008134059A1 (en) * 2007-04-30 2008-11-06 Medtronic, Inc. Shifting of electrical stimulation electrode combinations among differently sized electrode arrays
EP2152356A1 (en) * 2007-04-30 2010-02-17 Medtronic, Inc. Parameter-directed shifting of electrical stimulation electrode combinations
US8801636B2 (en) * 2007-07-19 2014-08-12 Cardiac Pacemakers, Inc. Method and apparatus for determining wellness based on decubitus posture
US9008782B2 (en) * 2007-10-26 2015-04-14 Medtronic, Inc. Occipital nerve stimulation
US7974702B1 (en) * 2008-01-10 2011-07-05 Pacesetter, Inc. Communication device, communication system and communication method for an implantable medical device
ATE531421T1 (en) * 2008-01-31 2011-11-15 Medtronic Inc ELECTRODE-LEAD CONNECTION WITH POST-IMPLANTATION IMAGING
US9220889B2 (en) 2008-02-11 2015-12-29 Intelect Medical, Inc. Directional electrode devices with locating features
US8019440B2 (en) 2008-02-12 2011-09-13 Intelect Medical, Inc. Directional lead assembly
US7890182B2 (en) * 2008-05-15 2011-02-15 Boston Scientific Neuromodulation Corporation Current steering for an implantable stimulator device involving fractionalized stimulation pulses
US9272153B2 (en) 2008-05-15 2016-03-01 Boston Scientific Neuromodulation Corporation VOA generation system and method using a fiber specific analysis
EP2321003B1 (en) 2008-05-15 2016-05-04 Intelect Medical Inc. Clinician programmer system and method for steering volumes of activation
US9254387B2 (en) 2011-08-09 2016-02-09 Boston Scientific Neuromodulation Corporation VOA generation system and method using a fiber specific analysis
US9662045B2 (en) * 2008-07-11 2017-05-30 Medtronic, Inc. Generation of sleep quality information based on posture state data
JP5653918B2 (en) 2008-07-30 2015-01-14 エコーレ ポリテクニーク フェデラーレ デ ローザンヌ (イーピーエフエル) Apparatus and method for optimized stimulation of neural targets
US20100030227A1 (en) * 2008-07-31 2010-02-04 Medtronic, Inc. Medical lead implantation
WO2010039853A1 (en) 2008-10-01 2010-04-08 Inspire Medical Systems, Inc. Transvenous method of treating sleep apnea
US8249701B2 (en) * 2008-10-15 2012-08-21 Spinal Modulation, Inc. Methods, devices and systems for programming neurostimulation
US8788064B2 (en) 2008-11-12 2014-07-22 Ecole Polytechnique Federale De Lausanne Microfabricated neurostimulation device
EP2346567A4 (en) 2008-11-13 2012-04-25 Proteus Biomedical Inc Multiplexed multi-electrode neurostimulation devices
US8644919B2 (en) 2008-11-13 2014-02-04 Proteus Digital Health, Inc. Shielded stimulation and sensing system and method
EP2389224B1 (en) 2008-11-19 2017-03-01 Inspire Medical Systems, Inc. Device treating sleep disordered breathing
US8995731B2 (en) * 2008-11-26 2015-03-31 Medtronic, Inc. Image-based characterization of implanted medical leads
US9486628B2 (en) 2009-03-31 2016-11-08 Inspire Medical Systems, Inc. Percutaneous access for systems and methods of treating sleep apnea
EP2470258B1 (en) 2009-08-27 2017-03-15 The Cleveland Clinic Foundation System and method to estimate region of tissue activation
US8571677B2 (en) * 2009-10-21 2013-10-29 Medtronic, Inc. Programming techniques for stimulation with utilization of case electrode
US8996123B2 (en) * 2009-10-21 2015-03-31 Medtronic, Inc. Managing electrical stimulation therapy based on variable electrode combinations
US20110093042A1 (en) * 2009-10-21 2011-04-21 Medtronic, Inc. Stimulation with utilization of case electrode
US8543202B2 (en) * 2009-11-25 2013-09-24 Steven M. Goetz Medical electrical stimulation with external simulated case electrode
JP2013512062A (en) 2009-12-01 2013-04-11 エコーレ ポリテクニーク フェデラーレ デ ローザンヌ Microfabricated surface nerve stimulation device and methods of making and using the same
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
EP2552536B1 (en) 2010-04-01 2016-06-08 Ecole Polytechnique Fédérale de Lausanne (EPFL) Device for interacting with neurological tissue
US9814885B2 (en) 2010-04-27 2017-11-14 Medtronic, Inc. Stimulation electrode selection
US9320901B2 (en) 2010-04-28 2016-04-26 Medtronic, Inc. Stimulation with utilization of non-selected electrode
US8731679B2 (en) 2010-04-29 2014-05-20 Cardiac Pacemakers, Inc. Implantable medical device configuration based on port usage
DE102010022026B4 (en) * 2010-05-29 2012-05-31 Cerbomed Gmbh Device for transcutaneous stimulation of a nerve of the human body
US8560080B2 (en) 2010-06-11 2013-10-15 Medtronic, Inc. Programming techniques for controlling rate of change of electrical stimulation therapy
EP2580710B1 (en) 2010-06-14 2016-11-09 Boston Scientific Neuromodulation Corporation Programming interface for spinal cord neuromodulation
US8965482B2 (en) 2010-09-30 2015-02-24 Nevro Corporation Systems and methods for positioning implanted devices in a patient
EP4201475A1 (en) 2011-01-03 2023-06-28 The Regents of the University of California High density epidural stimulation for facilitation of locomotion, posture, voluntary movement, and recovery of autonomic, sexual, vasomotor, and cognitive function after neurological injury
JP2014508581A (en) 2011-01-21 2014-04-10 カリフォルニア インスティテュート オブ テクノロジー Parylene-based microelectrode array implant for spinal cord stimulation
WO2012129574A2 (en) 2011-03-24 2012-09-27 California Institute Of Technology Neurostimulator
US9207845B2 (en) 2011-03-29 2015-12-08 Boston Scientific Neuromodulation Corporation System and method for atlas registration
US8406890B2 (en) 2011-04-14 2013-03-26 Medtronic, Inc. Implantable medical devices storing graphics processing data
US9592389B2 (en) 2011-05-27 2017-03-14 Boston Scientific Neuromodulation Corporation Visualization of relevant stimulation leadwire electrodes relative to selected stimulation information
EP2714187B1 (en) 2011-05-27 2021-11-10 Boston Scientific Neuromodulation Corporation Collection of clinical data for graphical representation and analysis
US20130172774A1 (en) 2011-07-01 2013-07-04 Neuropace, Inc. Systems and Methods for Assessing the Effectiveness of a Therapy Including a Drug Regimen Using an Implantable Medical Device
EP2742482B1 (en) 2011-08-09 2018-01-17 Boston Scientific Neuromodulation Corporation System and method for weighted atlas generation
WO2013023076A2 (en) 2011-08-09 2013-02-14 Boston Scientific Neuromodulation Corporation Control and/or quantification of target stimulation volume overlap and interface therefor
US8918183B2 (en) 2011-08-09 2014-12-23 Boston Scientific Neuromodulation Corporation Systems and methods for stimulation-related volume analysis, creation, and sharing
WO2013023218A1 (en) 2011-08-11 2013-02-14 Inspire Medical Systems, Inc. System for selecting a stimulation protocol based on sensed respiratory effort
WO2013033539A1 (en) 2011-09-01 2013-03-07 Boston Scientific Neuromodulation Corporation Methods and system for targeted brain stimulation using electrical parameter maps
US8934992B2 (en) 2011-09-01 2015-01-13 Inspire Medical Systems, Inc. Nerve cuff
US9081488B2 (en) 2011-10-19 2015-07-14 Boston Scientific Neuromodulation Corporation Stimulation leadwire and volume of activation control and display interface
AU2012334926B2 (en) 2011-11-11 2017-07-13 The Regents Of The University Of California Transcutaneous spinal cord stimulation: noninvasive tool for activation of locomotor circuitry
US10092750B2 (en) 2011-11-11 2018-10-09 Neuroenabling Technologies, Inc. Transcutaneous neuromodulation system and methods of using same
BR112014011409A2 (en) 2011-11-11 2017-05-02 Neuroenabling Tech Inc noninvasive neuromodulation device to enable recovery of motor, sensory, autonomic, sexual, vasomotor and cognitive function
EP2879757B1 (en) 2012-08-04 2019-06-26 Boston Scientific Neuromodulation Corporation Systems and methods for storing and transferring registration, atlas, and lead information between medical devices
EP2890451B1 (en) 2012-08-28 2021-09-22 Boston Scientific Neuromodulation Corporation Parameter visualization, selection, and annotation interface
US8983616B2 (en) 2012-09-05 2015-03-17 Greatbatch Ltd. Method and system for associating patient records with pulse generators
US9471753B2 (en) 2012-08-31 2016-10-18 Nuvectra Corporation Programming and virtual reality representation of stimulation parameter Groups
US8903496B2 (en) 2012-08-31 2014-12-02 Greatbatch Ltd. Clinician programming system and method
US9594877B2 (en) 2012-08-31 2017-03-14 Nuvectra Corporation Virtual reality representation of medical devices
US8868199B2 (en) 2012-08-31 2014-10-21 Greatbatch Ltd. System and method of compressing medical maps for pulse generator or database storage
US9180302B2 (en) 2012-08-31 2015-11-10 Greatbatch Ltd. Touch screen finger position indicator for a spinal cord stimulation programming device
US8812125B2 (en) 2012-08-31 2014-08-19 Greatbatch Ltd. Systems and methods for the identification and association of medical devices
US9507912B2 (en) 2012-08-31 2016-11-29 Nuvectra Corporation Method and system of simulating a pulse generator on a clinician programmer
US9375582B2 (en) 2012-08-31 2016-06-28 Nuvectra Corporation Touch screen safety controls for clinician programmer
US9615788B2 (en) 2012-08-31 2017-04-11 Nuvectra Corporation Method and system of producing 2D representations of 3D pain and stimulation maps and implant models on a clinician programmer
US8761897B2 (en) 2012-08-31 2014-06-24 Greatbatch Ltd. Method and system of graphical representation of lead connector block and implantable pulse generators on a clinician programmer
US8757485B2 (en) 2012-09-05 2014-06-24 Greatbatch Ltd. System and method for using clinician programmer and clinician programming data for inventory and manufacturing prediction and control
US9767255B2 (en) 2012-09-05 2017-09-19 Nuvectra Corporation Predefined input for clinician programmer data entry
US9792412B2 (en) 2012-11-01 2017-10-17 Boston Scientific Neuromodulation Corporation Systems and methods for VOA model generation and use
US9084897B2 (en) 2012-11-20 2015-07-21 Ams Research Corporation Tibial nerve stimulation therapy device calibration
US8918184B1 (en) 2013-03-12 2014-12-23 Medtronic, Inc. Identification of electrode combination for efficacious electrical stimulation therapy
JP6185142B2 (en) 2013-03-15 2017-08-23 ボストン サイエンティフィック ニューロモデュレイション コーポレイション Clinical response data mapping
AU2014228794B2 (en) 2013-03-15 2019-04-18 The Regents Of The University Of California Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion
WO2015048563A2 (en) 2013-09-27 2015-04-02 The Regents Of The University Of California Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects
EP3827874A1 (en) 2013-11-14 2021-06-02 Boston Scientific Neuromodulation Corporation Systems and visualization tools for stimulation and sensing of neural systems with system-level interaction models
US20150217120A1 (en) 2014-01-13 2015-08-06 Mandheerej Nandra Neuromodulation systems and methods of using same
US11383083B2 (en) 2014-02-11 2022-07-12 Livanova Usa, Inc. Systems and methods of detecting and treating obstructive sleep apnea
US11311718B2 (en) 2014-05-16 2022-04-26 Aleva Neurotherapeutics Sa Device for interacting with neurological tissue and methods of making and using the same
EP3476430B1 (en) 2014-05-16 2020-07-01 Aleva Neurotherapeutics SA Device for interacting with neurological tissue
US9959388B2 (en) 2014-07-24 2018-05-01 Boston Scientific Neuromodulation Corporation Systems, devices, and methods for providing electrical stimulation therapy feedback
US10272247B2 (en) 2014-07-30 2019-04-30 Boston Scientific Neuromodulation Corporation Systems and methods for stimulation-related volume analysis, creation, and sharing with integrated surgical planning and stimulation programming
US10265528B2 (en) 2014-07-30 2019-04-23 Boston Scientific Neuromodulation Corporation Systems and methods for electrical stimulation-related patient population volume analysis and use
WO2016029159A2 (en) 2014-08-21 2016-02-25 The Regents Of The University Of California Regulation of autonomic control of bladder voiding after a complete spinal cord injury
US9403011B2 (en) 2014-08-27 2016-08-02 Aleva Neurotherapeutics Leadless neurostimulator
WO2016033369A1 (en) 2014-08-27 2016-03-03 The Regents Of The University Of California Multi-electrode array for spinal cord epidural stimulation
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
EP3204112A1 (en) 2014-10-07 2017-08-16 Boston Scientific Neuromodulation Corporation Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
US10130813B2 (en) 2015-02-10 2018-11-20 Neuropace, Inc. Seizure onset classification and stimulation parameter selection
EP3881892A1 (en) 2015-03-19 2021-09-22 Inspire Medical Systems, Inc. Stimulation for treating sleep disordered breathing
US11167139B2 (en) 2015-03-20 2021-11-09 Medtronic Sg, Llc Method and apparatus for multi modal electrical modulation of pain using composite electromagnetic fields
US10434311B2 (en) 2015-03-20 2019-10-08 Stimgenics, Llc Method and apparatus for multimodal electrical modulation of pain
US10850102B2 (en) 2015-03-20 2020-12-01 Medtronic Sg, Llc Method and apparatus for multimodal electrical modulation of pain
US10780283B2 (en) 2015-05-26 2020-09-22 Boston Scientific Neuromodulation Corporation Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation
WO2016191436A1 (en) 2015-05-26 2016-12-01 Boston Scientific Neuromodulation Corporation Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation
WO2017209673A1 (en) * 2016-06-03 2017-12-07 Neuronano Ab Method and system for improving stimulation of excitable tissue
CA2987936A1 (en) * 2015-06-05 2016-12-08 Neuronano Ab Method and system for improving stimulation of excitable tissue
EP3280491B1 (en) 2015-06-29 2023-03-01 Boston Scientific Neuromodulation Corporation Systems for selecting stimulation parameters by targeting and steering
WO2017003946A1 (en) 2015-06-29 2017-01-05 Boston Scientific Neuromodulation Corporation Systems and methods for selecting stimulation parameters based on stimulation target region, effects, or side effects
EP3319688A4 (en) * 2015-07-10 2019-02-13 Neuronano AB Method and system for improving stimulation of excitable tissue
WO2017035512A1 (en) 2015-08-26 2017-03-02 The Regents Of The University Of California Concerted use of noninvasive neuromodulation device with exoskeleton to enable voluntary movement and greater muscle activation when stepping in a chronically paralyzed subject
US10071249B2 (en) 2015-10-09 2018-09-11 Boston Scientific Neuromodulation Corporation System and methods for clinical effects mapping for directional stimulation leads
US10561848B2 (en) 2015-10-13 2020-02-18 Regents Of The University Of Minnesota Systems and methods for programming and operating deep brain stimulation arrays
US11097122B2 (en) 2015-11-04 2021-08-24 The Regents Of The University Of California Magnetic stimulation of the spinal cord to restore control of bladder and/or bowel
WO2017134587A1 (en) 2016-02-02 2017-08-10 Aleva Neurotherapeutics, Sa Treatment of autoimmune diseases with deep brain stimulation
US10716942B2 (en) 2016-04-25 2020-07-21 Boston Scientific Neuromodulation Corporation System and methods for directional steering of electrical stimulation
EP3458152B1 (en) 2016-06-24 2021-04-21 Boston Scientific Neuromodulation Corporation Systems and methods for visual analytics of clinical effects
US10350404B2 (en) 2016-09-02 2019-07-16 Boston Scientific Neuromodulation Corporation Systems and methods for visualizing and directing stimulation of neural elements
US10780282B2 (en) 2016-09-20 2020-09-22 Boston Scientific Neuromodulation Corporation Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters
WO2018067239A1 (en) * 2016-10-04 2018-04-12 Medtronic, Inc. Cathode-minimized stimulation programming
US10603498B2 (en) 2016-10-14 2020-03-31 Boston Scientific Neuromodulation Corporation Systems and methods for closed-loop determination of stimulation parameter settings for an electrical simulation system
US10426949B2 (en) 2016-10-26 2019-10-01 Regents Of The University Of Minnesota Systems and methods for optimizing programming and use of neuromodulation systems
EP3515548B1 (en) 2017-01-03 2021-03-17 Boston Scientific Neuromodulation Corporation Systems and methods for selecting mri-compatible stimulation parameters
US10589104B2 (en) 2017-01-10 2020-03-17 Boston Scientific Neuromodulation Corporation Systems and methods for creating stimulation programs based on user-defined areas or volumes
US10625082B2 (en) 2017-03-15 2020-04-21 Boston Scientific Neuromodulation Corporation Visualization of deep brain stimulation efficacy
WO2018187090A1 (en) 2017-04-03 2018-10-11 Boston Scientific Neuromodulation Corporation Systems and methods for estimating a volume of activation using a compressed database of threshold values
EP3421081B1 (en) 2017-06-30 2020-04-15 GTX medical B.V. A system for neuromodulation
WO2019014224A1 (en) 2017-07-14 2019-01-17 Boston Scientific Neuromodulation Corporation Systems and methods for estimating clinical effects of electrical stimulation
US11298540B2 (en) 2017-08-11 2022-04-12 Inspire Medical Systems, Inc. Cuff electrode
EP3634569A1 (en) 2017-08-15 2020-04-15 Boston Scientific Neuromodulation Corporation Systems and methods for controlling electrical stimulation using multiple stimulation fields
US10729907B2 (en) 2017-10-20 2020-08-04 Neuropace, Inc. Systems and methods for clinical decision making for a patient receiving a neuromodulation therapy based on deep learning
US10702692B2 (en) 2018-03-02 2020-07-07 Aleva Neurotherapeutics Neurostimulation device
WO2019210214A1 (en) 2018-04-27 2019-10-31 Boston Scientific Neuromodulation Corporation Systems for visualizing and programming electrical stimulation
JP7295141B2 (en) 2018-04-27 2023-06-20 ボストン サイエンティフィック ニューロモデュレイション コーポレイション Multimodal electrical stimulation system and methods of making and using
EP3653256B1 (en) 2018-11-13 2022-03-30 ONWARD Medical N.V. Control system for movement reconstruction and/or restoration for a patient
DE18205817T1 (en) 2018-11-13 2020-12-24 Gtx Medical B.V. SENSOR IN CLOTHING OF LIMBS OR FOOTWEAR
EP3695878B1 (en) 2019-02-12 2023-04-19 ONWARD Medical N.V. A system for neuromodulation
US11481578B2 (en) 2019-02-22 2022-10-25 Neuropace, Inc. Systems and methods for labeling large datasets of physiological records based on unsupervised machine learning
US11612750B2 (en) 2019-03-19 2023-03-28 Neuropace, Inc. Methods and systems for optimizing therapy using stimulation mimicking natural seizures
US11654285B2 (en) * 2019-08-15 2023-05-23 Boston Scientific Neuromodulation Corporation Method and apparatus for subtraction-based programming of neurostimulation fields
US11413461B2 (en) 2019-11-25 2022-08-16 Medtronic, Inc. Independent control of electrical stimulation amplitude for electrodes for delivery of electrical stimulation therapy
DE19211698T1 (en) 2019-11-27 2021-09-02 Onward Medical B.V. Neuromodulation system

Citations (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515158A (en) 1980-12-12 1985-05-07 The Commonwealth Of Australia Secretary Of Industry And Commerce Speech processing method and apparatus
US4549548A (en) 1983-09-14 1985-10-29 Vitafin N.V. Pacemaker system with automatic event-programmed switching between unipolar and bipolar operation
US4823808A (en) 1987-07-06 1989-04-25 Clegg Charles T Method for control of obesity, overweight and eating disorders
US5033469A (en) 1987-11-12 1991-07-23 Medicompex S.A. Installation for neuromuscular electrical stimulation
US5443486A (en) * 1994-09-26 1995-08-22 Medtronic, Inc. Method and apparatus to limit control of parameters of electrical tissue stimulators
EP0730882A2 (en) 1995-03-08 1996-09-11 Telectronics N.V. An improved implantable cardiac stimulation system
US5690691A (en) 1996-05-08 1997-11-25 The Center For Innovative Technology Gastro-intestinal pacemaker having phased multi-point stimulation
US5775331A (en) 1995-06-07 1998-07-07 Uromed Corporation Apparatus and method for locating a nerve
US5893883A (en) 1997-04-30 1999-04-13 Medtronic, Inc. Portable stimulation screening device for screening therapeutic effect of electrical stimulation on a patient user during normal activities of the patient user
US5938690A (en) 1996-06-07 1999-08-17 Advanced Neuromodulation Systems, Inc. Pain management system and method
US6044303A (en) 1995-09-13 2000-03-28 Empi Corp. TENS device with electronic pain intensity scale
US6052624A (en) 1999-01-07 2000-04-18 Advanced Bionics Corporation Directional programming for implantable electrode arrays
US6234964B1 (en) 1997-03-13 2001-05-22 First Opinion Corporation Disease management system and method
US6238423B1 (en) 1997-01-13 2001-05-29 Medtronic, Inc. Apparatus and method for treating chronic constipation
WO2001083028A1 (en) 2000-04-27 2001-11-08 Medtronic, Inc. Patient directed therapy management
US20010049542A1 (en) 2000-05-11 2001-12-06 Florio Joseph J. System and method for automatically verifying capture during multi-chamber stimulation
WO2001093953A1 (en) 2000-06-05 2001-12-13 Advanced Neuromodulation Systems, Inc. Neuromodulation therapy system
WO2002009808A1 (en) 2000-07-26 2002-02-07 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US20020035384A1 (en) 1998-11-13 2002-03-21 Intermedics Inc. Implantable device and programmer system which permits multiple programmers
US6393325B1 (en) 1999-01-07 2002-05-21 Advanced Bionics Corporation Directional programming for implantable electrode arrays
US20020072780A1 (en) 2000-09-26 2002-06-13 Transneuronix, Inc. Method and apparatus for intentional impairment of gastric motility and /or efficiency by triggered electrical stimulation of the gastrointestinal tract with respect to the intrinsic gastric electrical activity
US6440090B1 (en) 1998-04-30 2002-08-27 Medtronic, Inc. Spinal cord simulation systems with patient activity monitoring and therapy adjustments
EP1249254A2 (en) 2001-04-12 2002-10-16 Pacesetter, Inc. System and method for automatically selecting electrode polarity during sensing and stimulation
US6473653B1 (en) 1996-04-04 2002-10-29 Medtronic, Inc. Selective activation of electrodes within an inplantable lead
US6480743B1 (en) 2000-04-05 2002-11-12 Neuropace, Inc. System and method for adaptive brain stimulation
US20020169484A1 (en) 2001-02-13 2002-11-14 Scott Mathis Multi-electrode apparatus and method for treatment of congestive heart failure
US20030004549A1 (en) 2000-10-26 2003-01-02 Medtronic, Inc. Method and apparatus to minimize the effects of a cardiac insult
US6516227B1 (en) 1999-07-27 2003-02-04 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US20030036783A1 (en) 2000-04-27 2003-02-20 Bauhahn Ruth Elinor Patient directed therapy management
EP1304137A2 (en) 2001-10-19 2003-04-23 Pacesetter, Inc. Anti-tachycardia pacing methods and devices
US6587724B2 (en) 1999-12-17 2003-07-01 Advanced Bionics Corporation Magnitude programming for implantable electrical stimulator
US6622048B1 (en) 1999-12-06 2003-09-16 Advanced Bionics Corporation Implantable device programmer
US20040041352A1 (en) 2000-06-15 2004-03-04 Kurt Hohe Flat gasket and method for the production thereof
US6735477B2 (en) 2001-07-09 2004-05-11 Robert A. Levine Internal monitoring system with detection of food intake
WO2004041352A1 (en) 2002-10-31 2004-05-21 Medtronic, Inc. Distributed system for neurostimulation therapy programming
US20040138711A1 (en) 2002-10-15 2004-07-15 Medtronic, Inc. Control of treatment therapy during start-up and during operation of a medical device system
US20040147816A1 (en) 2001-04-18 2004-07-29 Shai Policker Analysis of eating habits
US20040158298A1 (en) * 2000-07-13 2004-08-12 Gliner Bradford Evan Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US20040181262A1 (en) 2003-03-13 2004-09-16 Bauhahn Ruth E. Context-sensitive collection of neurostimulation therapy data
US20040267330A1 (en) 2003-04-25 2004-12-30 Lee Michael T. Generation of theraphy programs and program groups
US20050060009A1 (en) 2003-09-15 2005-03-17 Goetz Steven M. Selection of neurostimulator parameter configurations using genetic algorithms
US6889076B2 (en) 2001-03-30 2005-05-03 Transneuronix, Inc. Device and procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming
US20050149142A1 (en) 2004-01-07 2005-07-07 Starkebaum Warren L. Gastric stimulation responsive to sensing feedback
US20050209050A1 (en) 2004-03-15 2005-09-22 Dirk Bartels Interactive mobile device
US20050222638A1 (en) 2004-03-30 2005-10-06 Steve Foley Sensor based gastrointestinal electrical stimulation for the treatment of obesity or motility disorders
US20060036293A1 (en) 2004-08-16 2006-02-16 Whitehurst Todd K Methods for treating gastrointestinal disorders
US20060074459A1 (en) 2000-12-11 2006-04-06 Melina Flesler Acute and chronic electrical signal therapy for obesity
US7146223B1 (en) 2002-02-04 2006-12-05 Advanced Bionics Corporation Method for optimizing search for spinal cord stimulation parameter settings
WO2007117348A1 (en) 2006-04-12 2007-10-18 Medtronic, Inc. Autogeneration of neurostimulation therapy program groups
US7313440B2 (en) 2004-04-14 2007-12-25 Medtronic, Inc. Collecting posture and activity information to evaluate therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US109484A (en) * 1870-11-22 Improvement in thill-couplings
US4549A (en) * 1846-05-30 Improvement in plows
US5370672A (en) * 1992-10-30 1994-12-06 The Johns Hopkins University Computer-controlled neurological stimulation system
TW410757U (en) * 1999-10-13 2000-11-01 Lin Huei Liang Structure for fastening frame and hub of baby carriage
KR100580119B1 (en) * 2000-06-28 2006-05-12 주식회사 하이닉스반도체 Method of manufacturing a capacitor in a semiconductor device
AU2003301818A1 (en) * 2002-10-31 2004-06-07 Medtronic, Inc. Method and device for applying filter information to identify combinations of electrodes

Patent Citations (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515158A (en) 1980-12-12 1985-05-07 The Commonwealth Of Australia Secretary Of Industry And Commerce Speech processing method and apparatus
US4549548A (en) 1983-09-14 1985-10-29 Vitafin N.V. Pacemaker system with automatic event-programmed switching between unipolar and bipolar operation
US4823808A (en) 1987-07-06 1989-04-25 Clegg Charles T Method for control of obesity, overweight and eating disorders
US5033469A (en) 1987-11-12 1991-07-23 Medicompex S.A. Installation for neuromuscular electrical stimulation
US5443486A (en) * 1994-09-26 1995-08-22 Medtronic, Inc. Method and apparatus to limit control of parameters of electrical tissue stimulators
EP0730882A2 (en) 1995-03-08 1996-09-11 Telectronics N.V. An improved implantable cardiac stimulation system
US5775331A (en) 1995-06-07 1998-07-07 Uromed Corporation Apparatus and method for locating a nerve
US6044303A (en) 1995-09-13 2000-03-28 Empi Corp. TENS device with electronic pain intensity scale
US6473653B1 (en) 1996-04-04 2002-10-29 Medtronic, Inc. Selective activation of electrodes within an inplantable lead
US5690691A (en) 1996-05-08 1997-11-25 The Center For Innovative Technology Gastro-intestinal pacemaker having phased multi-point stimulation
US5938690A (en) 1996-06-07 1999-08-17 Advanced Neuromodulation Systems, Inc. Pain management system and method
US6238423B1 (en) 1997-01-13 2001-05-29 Medtronic, Inc. Apparatus and method for treating chronic constipation
US6234964B1 (en) 1997-03-13 2001-05-22 First Opinion Corporation Disease management system and method
US5893883A (en) 1997-04-30 1999-04-13 Medtronic, Inc. Portable stimulation screening device for screening therapeutic effect of electrical stimulation on a patient user during normal activities of the patient user
US6440090B1 (en) 1998-04-30 2002-08-27 Medtronic, Inc. Spinal cord simulation systems with patient activity monitoring and therapy adjustments
US20020035384A1 (en) 1998-11-13 2002-03-21 Intermedics Inc. Implantable device and programmer system which permits multiple programmers
US6052624A (en) 1999-01-07 2000-04-18 Advanced Bionics Corporation Directional programming for implantable electrode arrays
US6393325B1 (en) 1999-01-07 2002-05-21 Advanced Bionics Corporation Directional programming for implantable electrode arrays
US6516227B1 (en) 1999-07-27 2003-02-04 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US6622048B1 (en) 1999-12-06 2003-09-16 Advanced Bionics Corporation Implantable device programmer
US6587724B2 (en) 1999-12-17 2003-07-01 Advanced Bionics Corporation Magnitude programming for implantable electrical stimulator
US6480743B1 (en) 2000-04-05 2002-11-12 Neuropace, Inc. System and method for adaptive brain stimulation
US20030036783A1 (en) 2000-04-27 2003-02-20 Bauhahn Ruth Elinor Patient directed therapy management
WO2001083028A1 (en) 2000-04-27 2001-11-08 Medtronic, Inc. Patient directed therapy management
US20010049542A1 (en) 2000-05-11 2001-12-06 Florio Joseph J. System and method for automatically verifying capture during multi-chamber stimulation
WO2001093953A1 (en) 2000-06-05 2001-12-13 Advanced Neuromodulation Systems, Inc. Neuromodulation therapy system
US20020116036A1 (en) 2000-06-05 2002-08-22 Daignault Richard J. Neuromodulation therapy system and method
US20040041352A1 (en) 2000-06-15 2004-03-04 Kurt Hohe Flat gasket and method for the production thereof
US20040158298A1 (en) * 2000-07-13 2004-08-12 Gliner Bradford Evan Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
WO2002009808A1 (en) 2000-07-26 2002-02-07 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US20020072780A1 (en) 2000-09-26 2002-06-13 Transneuronix, Inc. Method and apparatus for intentional impairment of gastric motility and /or efficiency by triggered electrical stimulation of the gastrointestinal tract with respect to the intrinsic gastric electrical activity
US20030004549A1 (en) 2000-10-26 2003-01-02 Medtronic, Inc. Method and apparatus to minimize the effects of a cardiac insult
US20060074459A1 (en) 2000-12-11 2006-04-06 Melina Flesler Acute and chronic electrical signal therapy for obesity
US20020169484A1 (en) 2001-02-13 2002-11-14 Scott Mathis Multi-electrode apparatus and method for treatment of congestive heart failure
US6889076B2 (en) 2001-03-30 2005-05-03 Transneuronix, Inc. Device and procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming
EP1249254A2 (en) 2001-04-12 2002-10-16 Pacesetter, Inc. System and method for automatically selecting electrode polarity during sensing and stimulation
US20040147816A1 (en) 2001-04-18 2004-07-29 Shai Policker Analysis of eating habits
US6735477B2 (en) 2001-07-09 2004-05-11 Robert A. Levine Internal monitoring system with detection of food intake
EP1304137A2 (en) 2001-10-19 2003-04-23 Pacesetter, Inc. Anti-tachycardia pacing methods and devices
US7146223B1 (en) 2002-02-04 2006-12-05 Advanced Bionics Corporation Method for optimizing search for spinal cord stimulation parameter settings
US20040138711A1 (en) 2002-10-15 2004-07-15 Medtronic, Inc. Control of treatment therapy during start-up and during operation of a medical device system
WO2004041352A1 (en) 2002-10-31 2004-05-21 Medtronic, Inc. Distributed system for neurostimulation therapy programming
US20040181262A1 (en) 2003-03-13 2004-09-16 Bauhahn Ruth E. Context-sensitive collection of neurostimulation therapy data
US20040267330A1 (en) 2003-04-25 2004-12-30 Lee Michael T. Generation of theraphy programs and program groups
US20050060009A1 (en) 2003-09-15 2005-03-17 Goetz Steven M. Selection of neurostimulator parameter configurations using genetic algorithms
US20050149142A1 (en) 2004-01-07 2005-07-07 Starkebaum Warren L. Gastric stimulation responsive to sensing feedback
US20050209050A1 (en) 2004-03-15 2005-09-22 Dirk Bartels Interactive mobile device
US20050222638A1 (en) 2004-03-30 2005-10-06 Steve Foley Sensor based gastrointestinal electrical stimulation for the treatment of obesity or motility disorders
US7313440B2 (en) 2004-04-14 2007-12-25 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US20060036293A1 (en) 2004-08-16 2006-02-16 Whitehurst Todd K Methods for treating gastrointestinal disorders
WO2007117348A1 (en) 2006-04-12 2007-10-18 Medtronic, Inc. Autogeneration of neurostimulation therapy program groups

Non-Patent Citations (24)

* Cited by examiner, † Cited by third party
Title
Advisory Action for U.S. Appl. No. 11/698,655, mailed Jan. 19, 2010, 3 pages.
Final Office Action for U.S. Appl. No. 11/402,657, mailed Jun. 24, 2010, 12 pages.
Final Office Action for U.S. Appl. No. 11/698,655, mailed Nov. 2, 2009, 8 pages.
International Search Report and Written Opinion for PCT/US2004/002155, filed Jan. 27, 2004.
International Search Report and Written Opinion for PCT/US2004/012838, filed Apr. 26, 2004.
Notification of Transmittal of the International Preliminary Report on Patentability for PCT/US2004/002155 dated Jun. 30, 2005 (8 pgs.).
Notification of Transmittal of the International Preliminary Report on Patentability for PCT/US2004/012838 dated Aug. 30, 2005 (9 pgs.).
Office Action dated Apr. 4, 2008 for U.S. Appl. No. 11/402,652, (18 pages).
Office Action dated Dec. 28, 2009 for U.S. Appl. No. 11/402,657. 7 pgs.
Office Action dated Feb. 2, 2009 for U.S. Appl. No. 11/402,652, 9 pgs.
Office Action dated Jul. 27, 2009 for U.S. Appl. No. 11/402,652 , 10 pgs.
Office Action dated Mar. 12, 2010 for U.S. Appl. No. 11/404,069, 9 pgs.
Office Action dated Oct. 6, 2009 for U.S. Appl. No. 11/402,652, 10 pgs.
Office Action dated Sep. 17, 2008 for U.S. Appl. No. 11/402,652, 16 pgs.
Response to Final Office Action for U.S. Appl. No. 11/402,657, filed Aug. 20, 2010, 10 pages.
Response to Final Office Action for U.S. Appl. No. 11/698,655, filed Dec. 29, 2009, 12 pages.
Response to Office Action dated Jul. 3, 2008 for U.S. Appl. No. 11/402,652, (10 pages).
Responsive Amendment dated Jan. 6, 2010 for U.S. Appl. No. 11/402,652, 18 pgs.
Responsive Amendment dated Jun. 3, 2010 for U.S. Appl. No. 11/404,069, 14 pgs.
Responsive Amendment dated Mar. 26, 2010 for U.S. Appl. No. 11/402,657, 16 pgs.
Responsive Amendment dated May 1, 2009 for U.S. Appl. No. 11/402,652, 14 pgs.
Responsive Amendment dated Nov. 17, 2008 for U.S. Appl. No. 11/402,652, 15 pgs.
Responsive Amendment dated Sep. 21, 2009 for U.S. Appl. No. 11/402,652, 10 pgs.
Written Opinion dated Mar. 30, 2005, International Application No. PCT/US2004/012838.

Cited By (178)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8798754B2 (en) 2005-09-26 2014-08-05 Venturi Group, Llc Neural blocking therapy
US8630715B2 (en) 2006-04-12 2014-01-14 Medtronic, Inc. Rule-based stimulation program search
US10561835B2 (en) 2006-10-31 2020-02-18 Medtronic, Inc. Implantable medical lead with threaded fixation
US8768472B2 (en) 2007-11-05 2014-07-01 Nevro Corporation Multi-frequency neural treatments and associated systems and methods
US8774926B2 (en) 2007-11-05 2014-07-08 Nevro Corporation Multi-frequency neural treatments and associated systems and methods
US10918867B2 (en) 2009-01-29 2021-02-16 Nevro Corp. Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US8509906B2 (en) 2009-01-29 2013-08-13 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US9403013B2 (en) 2009-01-29 2016-08-02 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US10173065B2 (en) 2009-01-29 2019-01-08 Nevro Corp. Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US10179241B2 (en) 2009-01-29 2019-01-15 Nevro Corp. Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US11883670B2 (en) 2009-01-29 2024-01-30 Nevro Corp. Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US8849410B2 (en) 2009-01-29 2014-09-30 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US10195433B2 (en) 2009-04-22 2019-02-05 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US11759638B2 (en) 2009-04-22 2023-09-19 Nevro Corp. Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods
US8718782B2 (en) 2009-04-22 2014-05-06 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8712533B2 (en) 2009-04-22 2014-04-29 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8694109B2 (en) 2009-04-22 2014-04-08 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8792988B2 (en) 2009-04-22 2014-07-29 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8694108B2 (en) 2009-04-22 2014-04-08 Nevro Corporation Devices for controlling high frequency spinal cord modulation for inhibiting pain, and associated systems and methods, including simplified controllers
US8838248B2 (en) 2009-04-22 2014-09-16 Nevro Corporation Devices for controlling high frequency spinal cord modulation for inhibiting pain, and associated systems and methods, including simplified program selection
US9993645B2 (en) 2009-04-22 2018-06-12 Nevro Corp. Devices for controlling high frequency spinal cord modulation for inhibiting pain, and associated systems and methods, including simplified program selection
US8862239B2 (en) 2009-04-22 2014-10-14 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8868192B2 (en) 2009-04-22 2014-10-21 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8874222B2 (en) 2009-04-22 2014-10-28 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8874221B2 (en) 2009-04-22 2014-10-28 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8874217B2 (en) 2009-04-22 2014-10-28 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8880177B2 (en) 2009-04-22 2014-11-04 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8886328B2 (en) 2009-04-22 2014-11-11 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8886326B2 (en) 2009-04-22 2014-11-11 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8886327B2 (en) 2009-04-22 2014-11-11 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8892209B2 (en) 2009-04-22 2014-11-18 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8989865B2 (en) 2009-04-22 2015-03-24 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9592388B2 (en) 2009-04-22 2017-03-14 Nevro Corp. Devices for controlling high frequency spinal cord modulation for inhibiting pain, and associated systems and methods, including simplified contact selection
US10220209B2 (en) 2009-04-22 2019-03-05 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US10220208B2 (en) 2009-04-22 2019-03-05 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US20120203304A1 (en) * 2009-04-22 2012-08-09 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8428748B2 (en) 2009-04-22 2013-04-23 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US11786731B2 (en) 2009-04-22 2023-10-17 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8718781B2 (en) 2009-04-22 2014-05-06 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9248293B2 (en) 2009-04-22 2016-02-02 Nevro Corporation Devices for controlling high frequency spinal cord modulation for inhibiting pain, and associated systems and methods, including simplified program selection
US10226626B2 (en) 2009-04-22 2019-03-12 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US10245433B2 (en) 2009-04-22 2019-04-02 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US11229792B2 (en) 2009-04-22 2022-01-25 Nevro Corp. Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods
US10413729B2 (en) 2009-04-22 2019-09-17 Nevro Corp. Devices for controlling high frequency spinal cord modulation for inhibiting pain, and associated systems and methods, including simplified contact selection
US9480842B2 (en) 2009-04-22 2016-11-01 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US10463857B2 (en) 2009-04-22 2019-11-05 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9327125B2 (en) 2009-04-22 2016-05-03 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9327127B2 (en) 2009-04-22 2016-05-03 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US10471258B2 (en) 2009-04-22 2019-11-12 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9327126B2 (en) 2009-04-22 2016-05-03 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9333357B2 (en) 2009-04-22 2016-05-10 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9333360B2 (en) 2009-04-22 2016-05-10 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9333359B2 (en) 2009-04-22 2016-05-10 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9333358B2 (en) 2009-04-22 2016-05-10 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9387327B2 (en) 2009-04-22 2016-07-12 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8554326B2 (en) 2009-04-22 2013-10-08 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US10603494B2 (en) 2009-04-22 2020-03-31 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US10493275B2 (en) 2009-04-22 2019-12-03 Nevro Corp. Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods
US8509905B2 (en) * 2009-04-22 2013-08-13 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US11229793B2 (en) 2009-04-22 2022-01-25 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9409019B2 (en) 2009-07-28 2016-08-09 Nevro Corporation Linked area parameter adjustment for spinal cord stimulation and associated systems and methods
US8649874B2 (en) 2010-11-30 2014-02-11 Nevro Corporation Extended pain relief via high frequency spinal cord modulation, and associated systems and methods
US10258796B2 (en) 2010-11-30 2019-04-16 Nevro Corp. Extended pain relief via high frequency spinal cord modulation, and associated systems and methods
US9180298B2 (en) 2010-11-30 2015-11-10 Nevro Corp. Extended pain relief via high frequency spinal cord modulation, and associated systems and methods
US9295839B2 (en) 2011-09-08 2016-03-29 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US11883663B2 (en) 2011-09-08 2024-01-30 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9278215B2 (en) 2011-09-08 2016-03-08 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9283387B2 (en) 2011-09-08 2016-03-15 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9283388B2 (en) 2011-09-08 2016-03-15 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9327121B2 (en) 2011-09-08 2016-05-03 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US11298539B2 (en) 2011-09-08 2022-04-12 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US10493277B2 (en) 2011-09-08 2019-12-03 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9002460B2 (en) 2012-04-02 2015-04-07 Nevro Corporation Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection
US9604059B2 (en) 2012-04-02 2017-03-28 Nevro Corp. Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection
US8676331B2 (en) 2012-04-02 2014-03-18 Nevro Corporation Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection
US11247057B1 (en) 2012-06-22 2022-02-15 Nevro Corp. Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US10328256B1 (en) 2012-06-22 2019-06-25 Nevro Corp. Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US9833614B1 (en) 2012-06-22 2017-12-05 Nevro Corp. Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US9776007B2 (en) 2012-08-31 2017-10-03 Nuvectra Corporation Method and system of quick neurostimulation electrode configuration and positioning
US20140067006A1 (en) * 2012-08-31 2014-03-06 Greatbatch Ltd. Method and System of Quick Neurostimulation Electrode Configuration and Positioning
US9728981B2 (en) 2012-08-31 2017-08-08 Alfred E. Mann Foundation For Scientific Research Feedback controlled coil driver for inductive power transfer
US20140067016A1 (en) * 2012-08-31 2014-03-06 Greatbatch Ltd. Method and System of Bracketing Stimulation Parameters on Clinician Programmers
US10668276B2 (en) * 2012-08-31 2020-06-02 Cirtec Medical Corp. Method and system of bracketing stimulation parameters on clinician programmers
US9259577B2 (en) * 2012-08-31 2016-02-16 Greatbatch Ltd. Method and system of quick neurostimulation electrode configuration and positioning
US11338144B2 (en) 2013-03-15 2022-05-24 Alfred E. Mann Foundation For Scientific Research Current sensing multiple output current stimulators
US9044614B2 (en) 2013-03-15 2015-06-02 Alfred E. Mann Foundation For Scientific Research High voltage monitoring successive approximation analog to digital converter
US9981130B2 (en) 2013-03-15 2018-05-29 Alfred E. Mann Foundation For Scientific Research Current sensing multiple output current stimulators
US10603495B2 (en) 2013-03-15 2020-03-31 The Alfred E. Mann Foundation For Scientific Research Current sensing multiple output current stimulators
US9446241B2 (en) 2013-03-15 2016-09-20 Alfred E. Mann Foundation For Scientific Research Current sensing multiple output current stimulators
US9682237B2 (en) 2013-03-15 2017-06-20 Alfred E. Mann Foundation For Scientific Research High voltage monitoring successive approximation analog to digital converter
US10029090B2 (en) 2013-05-03 2018-07-24 Alfred E. Mann Foundation For Scientific Research Multi-branch stimulation electrode for subcutaneous field stimulation
US9789325B2 (en) 2013-05-03 2017-10-17 Alfred E. Mann Foundation For Scientific Research Implant recharger handshaking system and method
US9308378B2 (en) 2013-05-03 2016-04-12 Alfred E. Mann Foundation For Scientific Research Implant recharger handshaking system and method
US9221119B2 (en) 2013-05-03 2015-12-29 Alfred E. Mann Foundation For Scientific Research High reliability wire welding for implantable devices
US9433779B2 (en) 2013-05-03 2016-09-06 Alfred E. Mann Foundation For Scientific Research Multi-branch stimulation electrode for subcutaneous field stimulation
US9675807B2 (en) 2013-05-03 2017-06-13 Alfred E. Mann Foundation For Scientific Research High reliability wire welding for implantable devices
US9895539B1 (en) 2013-06-10 2018-02-20 Nevro Corp. Methods and systems for disease treatment using electrical stimulation
US10751536B1 (en) 2013-06-10 2020-08-25 Nevro Corp. Methods and systems for disease treatment using electrical stimulation
US9205273B2 (en) 2013-07-29 2015-12-08 Alfred E. Mann Foundation For Scientific Research High efficiency magnetic link for implantable devices
US9166441B2 (en) 2013-07-29 2015-10-20 Alfred E. Mann Foundation For Scientific Research Microprocessor controlled class E driver
US9855436B2 (en) 2013-07-29 2018-01-02 Alfred E. Mann Foundation For Scientific Research High efficiency magnetic link for implantable devices
US9155901B2 (en) 2013-07-29 2015-10-13 Alfred E. Mann Foundation For Scientific Research Implant charging field control through radio link
US9780596B2 (en) 2013-07-29 2017-10-03 Alfred E. Mann Foundation For Scientific Research Microprocessor controlled class E driver
US10447083B2 (en) 2013-07-29 2019-10-15 The Alfred E. Mann Foundation For Scientific Research Microprocessor controlled class E driver
US11722007B2 (en) 2013-07-29 2023-08-08 The Alfred E. Mann Foundation For Scientific Rsrch Microprocessor controlled class E driver
US10971950B2 (en) 2013-07-29 2021-04-06 The Alfred E. Mann Foundation For Scientific Research Microprocessor controlled class E driver
US10449377B2 (en) 2013-07-29 2019-10-22 The Alfred E. Mann Foundation For Scientific Research High efficiency magnetic link for implantable devices
US10149978B1 (en) 2013-11-07 2018-12-11 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
US10576286B1 (en) 2013-11-07 2020-03-03 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
US10569089B1 (en) 2013-11-07 2020-02-25 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
US10556112B1 (en) 2013-11-07 2020-02-11 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
US9409020B2 (en) 2014-05-20 2016-08-09 Nevro Corporation Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods
US10881857B2 (en) 2014-05-20 2021-01-05 Nevro Corp. Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods
US10173062B2 (en) 2014-05-20 2019-01-08 Nevro Corp. Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods
US11766566B2 (en) 2014-05-20 2023-09-26 Nevro Corp. Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods
US11730411B2 (en) 2014-08-15 2023-08-22 Axonics, Inc. Methods for determining neurostimulation electrode configurations based on neural localization
US9533155B2 (en) 2014-08-15 2017-01-03 Axonics Modulation Technologies, Inc. Methods for determining neurostimulation electrode configurations based on neural localization
US9427574B2 (en) 2014-08-15 2016-08-30 Axonics Modulation Technologies, Inc. Implantable lead affixation structure for nerve stimulation to alleviate bladder dysfunction and other indication
US9802051B2 (en) 2014-08-15 2017-10-31 Axonics Modulation Technologies, Inc. External pulse generator device and associated methods for trial nerve stimulation
US9700731B2 (en) 2014-08-15 2017-07-11 Axonics Modulation Technologies, Inc. Antenna and methods of use for an implantable nerve stimulator
US9802038B2 (en) 2014-08-15 2017-10-31 Axonics Modulation Technologies, Inc. Implantable lead affixation structure for nerve stimulation to alleviate bladder dysfunction and other indication
US11497916B2 (en) 2014-08-15 2022-11-15 Axonics, Inc. Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US10589103B2 (en) 2014-08-15 2020-03-17 Axonics Modulation Technologies, Inc. External pulse generator device and associated methods for trial nerve stimulation
US9855423B2 (en) 2014-08-15 2018-01-02 Axonics Modulation Technologies, Inc. Systems and methods for neurostimulation electrode configurations based on neural localization
US10478619B2 (en) 2014-08-15 2019-11-19 Axonics Modulation Technologies, Inc. Implantable lead affixation structure for nerve stimulation to alleviate bladder dysfunction and other indication
US9561372B2 (en) 2014-08-15 2017-02-07 Axonics Modulation Technologies, Inc. Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US9555246B2 (en) 2014-08-15 2017-01-31 Axonics Modulation Technologies, Inc. Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US10682521B2 (en) 2014-08-15 2020-06-16 Axonics Modulation Technologies, Inc. Attachment devices and associated methods of use with a nerve stimulation charging device
US11213675B2 (en) 2014-08-15 2022-01-04 Axonics, Inc. Implantable lead affixation structure for nerve stimulation to alleviate bladder dysfunction and other indication
US10729903B2 (en) 2014-08-15 2020-08-04 Axonics Modulation Technologies, Inc. Methods for determining neurostimulation electrode configurations based on neural localization
US10092762B2 (en) 2014-08-15 2018-10-09 Axonics Modulation Technologies, Inc. Integrated electromyographic clinician programmer for use with an implantable neurostimulator
US11116985B2 (en) 2014-08-15 2021-09-14 Axonics, Inc. Clinician programmer for use with an implantable neurostimulation lead
US11389659B2 (en) 2014-08-15 2022-07-19 Axonics, Inc. External pulse generator device and associated methods for trial nerve stimulation
US10406369B2 (en) 2014-08-15 2019-09-10 Axonics Modulation Technologies, Inc. Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US10449360B2 (en) 2014-09-15 2019-10-22 Boston Scientific Neuromodulation Corporation Graphical user interface for programming neurostimulation pulse patterns
US9737717B2 (en) 2014-09-15 2017-08-22 Boston Scientific Neuromodulation Corporation Graphical user interface for programming neurostimulation pulse patterns
US11235155B2 (en) 2014-09-15 2022-02-01 Boston Scientific Neuromodulation Corporation Graphical user interface for programming neurostimulation pulse patterns
US9802052B2 (en) 2014-11-04 2017-10-31 Boston Scientific Neuromodulation Corporation Method and apparatus for programming complex neurostimulation patterns
US11484723B2 (en) 2015-01-09 2022-11-01 Axonics, Inc. Attachment devices and associated methods of use with a nerve stimulation charging device
US10384067B2 (en) 2015-01-09 2019-08-20 Axonics Modulation Technologies, Inc. Patient remote and associated methods of use with a nerve stimulation system
US10105542B2 (en) 2015-01-09 2018-10-23 Axonics Modulation Technologies, Inc. Patient remote and associated methods of use with a nerve stimulation system
US9770596B2 (en) 2015-01-09 2017-09-26 Axonics Modulation Technologies, Inc. Antenna and methods of use for an implantable nerve stimulator
US11478648B2 (en) 2015-01-09 2022-10-25 Axonics, Inc. Antenna and methods of use for an implantable nerve stimulator
US11123569B2 (en) 2015-01-09 2021-09-21 Axonics, Inc. Patient remote and associated methods of use with a nerve stimulation system
US10722721B2 (en) 2015-01-09 2020-07-28 Axonics Modulation Technologies, Inc. Antenna and methods of use for an implantable nerve stimulator
US9895546B2 (en) 2015-01-09 2018-02-20 Axonics Modulation Technologies, Inc. Patient remote and associated methods of use with a nerve stimulation system
US11766568B2 (en) 2015-07-10 2023-09-26 Axonics, Inc. Implantable nerve stimulator having internal electronics without ASIC and methods of use
US9925381B2 (en) 2015-07-10 2018-03-27 Axonics Modulation Technologies, Inc. Implantable nerve stimulator having internal electronics without ASIC and methods of use
US10850104B2 (en) 2015-07-10 2020-12-01 Axonics Modulation Technologies, Inc. Implantable nerve stimulator having internal electronics without ASIC and methods of use
US10335601B2 (en) 2015-07-30 2019-07-02 Boston Scientific Neuromodulation Corporation User interface for custom patterned electrical stimulation
US11071868B2 (en) 2015-07-30 2021-07-27 Boston Scientific Neuromodulation Corporation User interface for custom patterned electrical stimulation
US11607551B2 (en) 2015-07-30 2023-03-21 Boston Scientific Neuromodulation Corporation User interface for custom patterned electrical stimulation
US11331487B2 (en) 2015-10-15 2022-05-17 Boston Scientific Neuromodulation Corporation User interface for neurostimulation waveform composition
US10456586B2 (en) 2015-10-15 2019-10-29 Boston Scientific Neuromodulation Corporation User interface for neurostimulation waveform composition
US11890470B2 (en) 2015-10-15 2024-02-06 Boston Scientific Neuromodulation Corporation User interface for neurostimulation waveform composition
US11318310B1 (en) 2015-10-26 2022-05-03 Nevro Corp. Neuromodulation for altering autonomic functions, and associated systems and methods
US11458317B1 (en) 2015-12-14 2022-10-04 Nevro Corp. Variable amplitude signals for neurological therapy, and associated systems and methods
US10300277B1 (en) 2015-12-14 2019-05-28 Nevro Corp. Variable amplitude signals for neurological therapy, and associated systems and methods
US10195423B2 (en) 2016-01-19 2019-02-05 Axonics Modulation Technologies, Inc. Multichannel clip device and methods of use
US9517338B1 (en) 2016-01-19 2016-12-13 Axonics Modulation Technologies, Inc. Multichannel clip device and methods of use
US11596798B2 (en) 2016-01-25 2023-03-07 Nevro Corp Treatment of congestive heart failure with electrical stimulation, and associated systems and methods
US11602638B2 (en) 2016-01-29 2023-03-14 Axonics, Inc. Methods and systems for frequency adjustment to optimize charging of implantable neurostimulator
US10603500B2 (en) 2016-01-29 2020-03-31 Axonics Modulation Technologies, Inc. Methods and systems for frequency adjustment to optimize charging of implantable neurostimulator
US11083903B2 (en) 2016-01-29 2021-08-10 Axonics, Inc. Methods and systems for frequency adjustment to optimize charging of implantable neurostimulator
US10376704B2 (en) 2016-02-12 2019-08-13 Axonics Modulation Technologies, Inc. External pulse generator device and associated methods for trial nerve stimulation
US11260236B2 (en) 2016-02-12 2022-03-01 Axonics, Inc. External pulse generator device and affixation device for trial nerve stimulation and methods of use
US10799701B2 (en) 2016-03-30 2020-10-13 Nevro Corp. Systems and methods for identifying and treating patients with high-frequency electrical signals
US11446504B1 (en) 2016-05-27 2022-09-20 Nevro Corp. High frequency electromagnetic stimulation for modulating cells, including spontaneously active and quiescent cells, and associated systems and methods
US11633604B2 (en) 2018-01-30 2023-04-25 Nevro Corp. Efficient use of an implantable pulse generator battery, and associated systems and methods
US11511122B2 (en) 2018-02-22 2022-11-29 Axonics, Inc. Neurostimulation leads for trial nerve stimulation and methods of use
US11110283B2 (en) 2018-02-22 2021-09-07 Axonics, Inc. Neurostimulation leads for trial nerve stimulation and methods of use
US11058875B1 (en) 2018-09-19 2021-07-13 Nevro Corp. Motor function in spinal cord injury patients via electrical stimulation, and associated systems and methods
US11801382B1 (en) 2018-09-19 2023-10-31 Nevro Corp. Motor function in spinal cord injury patients via electrical stimulation, and associated systems and methods
US11602634B2 (en) 2019-01-17 2023-03-14 Nevro Corp. Sensory threshold adaptation for neurological therapy screening and/or electrode selection, and associated systems and methods
US11590352B2 (en) 2019-01-29 2023-02-28 Nevro Corp. Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods
US11642537B2 (en) 2019-03-11 2023-05-09 Axonics, Inc. Charging device with off-center coil
US11848090B2 (en) 2019-05-24 2023-12-19 Axonics, Inc. Trainer for a neurostimulator programmer and associated methods of use with a neurostimulation system
US11439829B2 (en) 2019-05-24 2022-09-13 Axonics, Inc. Clinician programmer methods and systems for maintaining target operating temperatures

Also Published As

Publication number Publication date
DE602004008905D1 (en) 2007-10-25
EP1617897B1 (en) 2011-05-25
EP1617905B1 (en) 2007-09-12
US20070123953A1 (en) 2007-05-31
WO2004096358A3 (en) 2005-01-27
US20040267330A1 (en) 2004-12-30
US20060195145A1 (en) 2006-08-31
US20040215288A1 (en) 2004-10-28
US8649872B2 (en) 2014-02-11
US20120078325A1 (en) 2012-03-29
US8068915B2 (en) 2011-11-29
WO2004096358A2 (en) 2004-11-11
US7463928B2 (en) 2008-12-09
ATE372810T1 (en) 2007-09-15
WO2004096349A1 (en) 2004-11-11
US9186517B2 (en) 2015-11-17
ATE510583T1 (en) 2011-06-15
EP1617905A2 (en) 2006-01-25
EP1617897A1 (en) 2006-01-25
DE602004008905T2 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
US7826901B2 (en) Generation of therapy programs and program groups
US7853323B2 (en) Selection of neurostimulator parameter configurations using neural networks
EP1670546B1 (en) Selection of neurostimulator parameter configurations using genetic algorithms
US8155749B2 (en) Management of neurostimulation therapy using parameter sets
US7894908B2 (en) Neurostimulation therapy optimization based on a rated session log
US7617002B2 (en) Selection of neurostimulator parameter configurations using decision trees
US7774067B2 (en) Autogeneration of neurostimulation therapy program groups
US7548786B2 (en) Library for management of neurostimulation therapy programs
US7603177B2 (en) Applying filter information to identify combinations of electrodes
US7505815B2 (en) Neurostimulation therapy usage diagnostics

Legal Events

Date Code Title Description
AS Assignment

Owner name: MEDTRONIC, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LEE, MICHAEL T.;GOETZ, STEVEN M.;TORGERSON, NATHAN A.;REEL/FRAME:015720/0057;SIGNING DATES FROM 20040804 TO 20040805

Owner name: MEDTRONIC, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LEE, MICHAEL T.;GOETZ, STEVEN M.;TORGERSON, NATHAN A.;SIGNING DATES FROM 20040804 TO 20040805;REEL/FRAME:015720/0057

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552)

Year of fee payment: 8

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 12